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A. Pharmacological Action and Oherdcal Structure in the 'Barbituric 
Aeid Derlvlltive Sen_. 
,(1) PrepaNt111n,_tiJod&. 
In 'beginning the dUCWJ8ton ot this topic it is perUDant to preaent 
801le or the fundamental pl"1no1ples 01 the methods used in the 81Jltbesia ot 
the barb! turie acid series. 
Barbituric aaid is qnthetiHd by' condensation 01 urea yith the 
d1eth71esteJt ot .:tonio acid in the presence ot sodium ethox1de. !be six-
membered ring ot barbituric acid is known either &8 a ~d1ne or .. a 
l,l-d1u1ne 1'1111. (Fieser and Fieaer, 19$0). 
~ (4) 
"r.···.··,,··.. H 0 /NH~H CLHsdoc 6.' or IH ~-c..C CO :..... + ............ ~ 'CH ,1'4Q '"I.i ~ ''''CO H ") 
"NHr'" ~H"'aO~ 2. ~" / 1.\5 Jj so • N-c 
............. ; H 0 
(0 (6) 
111. derivatives ot})vbi tunc acid are valuable agents in medicine 
and an COM!IIOnq known as ttbarbi tul"8tesft • '!he pioneers in this field were 
F.. Fischer and von 'M'erJ"lng in 1903. '!hey in troduced 5,S ... dieth¥l barb! tune 
acid .. a ~t1c drug. (l"1eeer and F'1eser, 19$0). 
1 
2 
" 
1t1e synthesis of a "barbiturate" oan be Ulutrated by the following 
example. It a derivative ot barbiturio acid with two identical al.kyl rad10ala 
on 0U'b0n tive is de8ired one proceeds in the tollov1ng ft7l 
(,3) l&t) 
/'N H(H' C~'H~'O~C, N rv-H /~-~, <,5) 
CO ~ ...... + ......... ".! CR... a.v~ ;(tJco CR ... +~ 'C,.H ... OH 
" :'.... II •••••••• ,.t ~ __ ~;&. .~ 
N H~H C2.Hs<l:OC/ 'N-C 
U'f"t .I., •• , •••• ~ H 0 
(II 16 1 
It 'bfo ditferent earbon tive Bubstttutione are desired one has to 
prepare the mon08ubatt t.uted Jl&1.oni c ester usmc 't.!'le toUowingmethod (Burpr, 
19S1): 
N= CC H2.COCR' + O=CR~ -~) N=C~COOR+ H~O 
CR" 
N~CCCOORI 
CR" <t 
N=cc HCOO~: HC~' ,. 
+ Hl. 
+ RIOH 
~ 
-~) N~C CHeDORI 
HCR~ 
Hl.O) R'OOC.C.HCOOR' 
HCp.:~ 
1b1s p1"OO«lu.re 18 required becau8e the reaction tor direot 1ntroduc-
tdon ot one al.1q'1 radioal cannot be wen controlled, giving '. JIIlxture of the, 
mono- and dieubaU .. ted malon1e acid eaten. Their steM tl"act.ioning 18 
rather d1tt1eult eapec1a117 in c .... where small radlO&la are introduced. 'lbe 
second alkyl radical is added by the conventional _thode. 'lbe diaubstituted 
malonic acid eater obtained is condensed with urea u described in preC«ling 
paragl'llpbe (Dlrger, 19S).). 
'lbe" are Mthods tor introducing the alk71 radicala dtrec\l7 into 
barb!. tunc acid ring .. Ul1.t8tl"ated below (Burgel", 1951): 
.. 3 
The tb10barbl turatee are prepared when thiourea, 1a condenled wi\b 
eth71 malonic acid ester (Adrian1, 19U2)r H 0 /NH~H'" C';H:OoC, /N-C, CS ........ ....L............... CR --")oC5 /C£:) 
....... -.- ...••.• -.... l.. ''\1. 
'NH;H C~H doc 'N-C 
\..... • ...... ,,~ •••• ! ~ 0 
1be subat1tut1on8 on n1tJ:rogen are done using tHM'th7laul..tate tor 
meth71atlon or d1etb71eultate tor eth7lation ot the S,S-d1eubati t.uted barbi-
turic acid (Bush .and Butler, 1937). For Introduction of other radioals 
epecID methode have been deYeloped. (Hen .. and Spurlock, 19L1). 
Use of the &baYe de8cribed methode of a1l1tha1a or their modi1'1eat1ona 
has made preparation of a very large nUJllber of barbitunt.ea poaaible. JUrth.fIo 
more, a vutev ot pba.cologloal eft.eu &reproduced 'b7 dltterent substi-
tuted groups depending on whether t.l-te)" are straight, branched, unaaturated or 
O7011c in their charGeter. 1htee facta Mke the consideration of chemical. 
atNcture and acUrlV NlaUcme rather oomplex. 
(2) Substitutions on Carbon Fin and PhaJomacological Action. 
,t1tIulat1ng ActIo!1- Moat 1iOric: on the llOd1t1eatlon of the barbltur:l.c 
acid llIOleoule bas been done b7 chanrmg the aum.tituent. on carbon tift. 'lb. 
characteristio hypnoUc pharmacological action .... to depend on the double 
substitution because the un8ubetltuted or JtOnollubstttuted barbituric acids do 
• 
not have any 8ignif'1cmlt hypnotic action. Shonle (l93l) stated that introduc-
tion of hy'dro:x;yl, etho~l, e8l"barql, amino or cs.rboql groupe into one of' tbe 
alkyl groups either dest.ro)"s the tvJmotic effect of' the disubetltuted barbi-
turic acid or creates convulsive activit,._ ReplacIng one of the alkyl group. 
by' some physiologically active group, e.g. acetone, ether, reeults in inert 
col'!'lpOUnds. lhe introrluetiODof am1.'\o, n1 tl'O or byd1'OlO'l groupe in the pbenyl 
radical of $,S"'phe:nylethy'l barb! tune acid causes loss of ·nctiY1ty. Bl'Omine 
or chlorine increase the toxiet V.. The introduction of tho special groups, 
e.g. beneyl radical, into' carbon 1'1''9'9 (Dox and yOties, 1m; Blieke and 
Zlooty, 19ltl) results in convulsive compoundl. Fol"ntSrly 1 t tiM thO'.lght 
(~honlet1931) that compounds vi th highly :reactive g1"Oupe on carbon tive were 
responsible for the conw1s1ft character. nowever, now we have numerous de-
p:res!.d.ve barbituratea1ftich oonta1n very reactive groupe, e.g. allyl, on 
carbon tive. Knoorel (19J,6) va of the opinion that the introduction of the 
double bond into a brancbed ohain 11M anbt>Ortant factor eau&ing the con ... 
vulsive properties. For eDIIIPle, 5,5- (l,J-dimethylpentyl) or 5,5-(1,L-di-
methylptmtyl) ethyl barb1 tur1c acid are depressant whUe the unsaturated 
analogs oE the $,5-C21ethylpropyl) meth8.l.ly'l barbiturio acid or S,$-(l-ethyl ... 
butTl) ethyl barbituric acld have proved to be eonvulaive. It i.8 interesting 
to note that t~!e introduction ot the double bond into $,$-(1,3-dimetllylbut:;1) 
01:1171 barbtturto acid do .. not inC!"ease its cOllvulsive potency. Velluz (l95la.i 
described a senes ot the stl!'1'1Ul.ant barbi tun tee whioh oan be 8Ul11!!arized in 
the following table, in decreasing order ot the COl1wleive potenc7' 
llBLE I 
R R' n" 
< >=CH-CH2- C2HS H-
~H3 ... c - CH-CH2- Id. , 013-PH 3" 
I >=ca- ctI2- Id., H-
CH3'c 00- 002- Id., Id., CHi" 
< >=CH-OH2- CH3- Id., 
Id., C2H,- at;-
Id., 
°6H,- H-
~lelluz (l9$la.) showed that analogues S,' ... (l,)-d1Methylbut,yl) etn;yl 
barbituric acid were depressant when 1,J ... diMeth)rlbutyl vas eharwed by the· 
following radlcalet CH3- CH2"'C~ CH{r'H3 ) .... CH3-~-eH(m~)r.l~-CH(CH3)-' 
CH3-CH(CH3) ... C~-CH2CH(CH3)"" CH3-CH(CH3 )-Clt2-OH2'. 'lhe analogue of $,5-diallyl 
barbi turie acid as S,$-dtmethylallyl barbituric acid proved to be stimulant 
where. S,,-al17L"Iethylallyl barb! tune acid proved to be deprt.'Ssant. 
Frtml the above examples one might say that the presence of the double 
bond in a branched chain or chain coutal.n1ng cyclic !'&dicals is an L~rtant 
-6 
.. 
condition in order to produce stimulating properUea. But the other mUie .. l 
on carbon f1ve has to be considered. The .following table above the barbi-
turic acids containing the (C.H3)2. ~·CH-CH2" group can be depressive depending 
on the nature of the second substituent. 1he compounds are listed in orda!' 
of the degree of the preanesthetic ~ tatory and hypnotic potenO;Yll 
TABLE II 
ft R' LJegl"8e 01: Dtc1 ta. tion 
Betore Aneethesia 
~3- O=CH-cH2- OH3- O .. CH-OH2- + +-+ PHj . CHi 
Id., C61IS-CH2- + + 
Iel. , N.C4~- + 
Id., Seo. C4!~- +-
XeL, ~H5- 0 
Id., C6~! 0 
one can uk at this poin t of the d1.c:ru~a1on 1Ihether or not these 
s~ating co'l'lTpOUnds might be ueed a.El analeptic ~ente in various depressive 
conditiona. The a11thor 18 not aware of any clinical trials or this po8sibi11 
tl", but 81'11-.1 experi'!Yl4!!nts indlcate that these compounds can antagonize aome 
depressive atates. Knoetel (19)6) reported the stJ.mu.1ating potenq' of S,$ 
--
1 
(1,J-dimGthy1butyl) ethyl barbiturio acid 1n ~ts abiliv to stimulate the 
reflex acti.on ot the M. tibialis in spinal dog preparations or in dogs an ... 
oB thetised vi til barbital. It proved to be l/2S0th. ae active ae s try'Clmine 
and IJ4th u active as pieritoxin, resG'"!hling the tirst'more than the second 
in its 8ppal"ent site ot action. It prodtlced more st1mul.ant ettecta than 
caffeine, oocaine, or ephedrine. Swanson and Chen (1939) shoved that this 
compound is 'Very coovulaive :in V&rr!I blooded animala whU. depressant in cold 
blooded aniala. Premedication li7 a dep:rusive barbiturate raised the lethal 
dose ot this eDmpound a .fewtold but p!"tmledication w1 til it did not raise the 
lethal dos. ot a depressive barbiturate. One can eonelude that theroe is no 
.ltual an tagonism between these compounds. SWanson '" tincl.:1nga were confirmed 
Knoerel (191,5). In vitro studi€:'3 by Fuhman et &1., (19M) showed that 
- --
thill compound attected brain respiration in the same way as common depressant 
arbiturates. B&llem 8t al., (19M3) Obs81'9'ed that S,S-(J,3-di'I'lletl'lylallyl) 
--
tIl,.1 barbi tur1c acid cause ..... tlessnes8 in doge and an increased gastric 
eOl"etion through the parasympathetic syetem. Noble (19L9) towld that $,5-
l,3-d1methylbutenyl) eth71 barbituric aaid increases gastric secretion but 
. iniatration of pentobarbital abolished thie etfect. Tqlor and Noble (1949) 
."ined the pharmacological properties ot S,S-( 3,3-d1llethylally1) ethyl 
1OI!LPf).i tul"ie acid t!ndiJlfr, that it increased the blood. pressure. rate and depth 
t res:pira tion, bod,y temperature, and that pentoba!bi tal could prevent the 
bon deseribed 8~. Velluz (19Slb) using S,S(lf~-qolopentamethylaneall,yJ) 
th7l barbituric aoid showed its respiratory stimulnting action in uretheni .. d 
abbi t. In comparison wi til eafteine 1. t was more potent and taster aoting. 

r 
! 
9 
• 
smallest MAD and shortest. duration of action. '!he effect. of the change in 
position of the methyl radical is such that the .normal pent)"l derivative has 
the largest 'MAD and longest duration of action. 
Karlier workers have reb. ted this increased effectiveness of the see-
bu tyl and sec-amyl groups to the prosen ce of groups having optical. acti vi t:y. 
:towevel", there is experimental proof that au ch enhanced activity does not 
depend on the presence of suob. groups (Shonle, 1931>-
'lb.. brmohed derivattfts such as 5,S"'propylmethyl,('arbanyletbyl barbi-
turic acid or 5,S-diethylcarba.nylethyl barb1 tune acid have approximately 
equal degrees of effectiveness. '!he 5,5-cyclopentylethyl barbituric acid con-
taining a cyelic secondary group, has the actiVity resembling that of the 
pri.lfIary series rather than that ot the secondary series (Shonle, 19.31). 
It an at.hy1 ~cu:p (Shonle, 19.31) is replaced by a larger group, e.g. 
prop,yl, the hypnotic effectivenees is reduced. S,S-sec-butyl n-propyl barbi-
turic aoid has less bJpnot1c action than >,5-sec-bu\Vlethyl barbituric acid. 
Tbe fomer has the IHlM molecular welght as the S,S-sec-amyletby1 barbit.urio 
acid but t.his compound has the greater hypnotic poteS1C7- These ezamp1ea il-
lustrate that bot.h molecular weight and the iIIOfl'lfU"io stJ'llcture ot al.lql Bub-
8U tuents are important fao'WZ'II in detem1ning the Phll.J"m&cologieal propert1ae. 
When the ethyl group 18 replaced by an allyl group certain differences 
are observed (Shanle. 19)1). In the primal'7 asnes the l!JJaXiJImm h1Pnotio et .. 
tioac:y and toxic1ty lie betveen the propyl and butyl groups. In tM eeoondar"J 
serios the sa_ ma.xi1'll1ll'! lif!'8 between the bu~l and the amyl g1'OU!'s. 1)1 COI!-
paring the an71 f;roups ot this series the iaop.l"ima.r.y is considerably more 
10 
• 
effecti". tLan the primar.y whereas the pri~&r7 c,yclopenty1 18 1Il0re effective 
than elther ot theBe or seeoll.dary eyc~nty1. In the S,S-alk:ylallyl barbi-
turic acid series wi t.h increasinc molecular weight the therapeutic ratio in-
creasee to a. l'IVIXi.muM of aoout 2.$ and V.n generally dropa. Unsaturation 
usually increa.st~S the effeotiver1*:138 provided the two substituted groupe have 
like nUl'l'lber ot carbon atome, e.g. S,S-s8c-butyla1l.yl barbituric acid shows 
increased effecti.veness and tOXicity. Silonle and Waldo (1933) prepared un-
saturated derivatives of ,,$-eec-butylethyl and 5,S-he:xylethyl bubi tur1c 
acids. 'lhasa cortpounds in 8M&l1 doses produced ronwlsione arId even in higher 
dosos {taft poor anesthesia. 'lbe to::d.ei t7 increases with greater molecular 
weight and with increuing degree ot unsaturat1on.. Cope am Hancock (1939) 
indicated that the unsaturated radical and alkyl barbituric acids e.g. i80-
propenyl. alkyl or dial.lqlvin71 alkyl conrpounds tollow app~tely the lame 
rules of effectiveness ~.e., the maxi!!rutll of effioacy- is reached With butTl and 
am,;yl der-lvatives. '!his generalisation is in tail' agreement with Shonle" 
statef\1ents (Sbonle, 1931). 
At the end or the discuesion of the suhat! tution on carbon five a 
new class of barbituric acid derivatives, the sp1robarbitUl"ates should be 
mentioneQ. 'lhese compounds are structures in which the carbon five at.om i. 
a constituent ot both the barbiturate ring and 'th.e substituted group, also a 
ring structure (Cope et. &1., 19h9). 'lbese COl'l1pounds an an exception to the 
- -
rulE' that replacement of both valences at C five by one group gives inactive 
o ~1. 
./ C, c." ,.",. eN ........ c. ~ , (/ " C. ~ e, leo 
......... ,' "'./ ....... ,, 3/ 
.......... c..---c. '" "c. N 
o lil., 
compounds. 
II 
• 
SUbati tutions have been made in this group of compounds on carbons 
3' 'I' 6'. In the series with a double bond betwem carbons J' and ht the 
hypnotic and toxic properties increase vi th increasing 1ftOlecular weight. Tbe 
c~und vith optimum therapeutic tndex is the 6' isopl'Op)"l or propyl deriva-
tive. 
'Before concluding this discu8Sion, the .findings by Butler and Bu8h 
(191J2) are worth mentioning. 'lhe:J.r series of barbituriC acid derivat:lYee con-
tained tJlo lonEl: chains on carbon five ginng comparativelT effective short 
acting barbIturates. on the basis or their findings they concluded that the 
old g8leralizations on the structure and activity relationship should 'be 
accepted vi th caution because this new series does not con ton to older rules 
set by ppevioua wo rkel"8. 
en Substi tutione on ~i trogen and Pharmacological Action. 
Dox and Hjort (1927) reported that the introduction ot the alkyl 
~ups on nitrogen one in S,S-dialkyl barb! tunc acid tailed to enhance the 
action of the parent compound. 'Itte introduction of the meth;y.l and ethyl 
groupe shortened the induction period and duration of anesthesia while increas-
ing the 'MAn in I'I!JOst cases. SWanson (1936) obaened that the ?f-ethyl deriva-
ttvea of S,$ ... dialkyl barb! tunc acid required larger doses for anesthesia than 
did the methyl derivative. Tabem and "olviller (19)6) -described the phama-
eologieal properties or. N-subetituted barbituric acida in 80J'!t8 detail stating 
that the hypnotic effect co •• ver:f rapidly (the animal 1s asleep with the 
c:.Km'Ipletion at irtjection) lI'ld the recovery is fast. In general the most satie-
12 
factory compounds are secured when one group on carbon t1ve is secondary the 
other is Mthyl and the nitrogen 8ubsti tuent i8 meth71. 'he attach:mfmt ot 
large pri"llary, secondary or tertiary Vroupe on N one leads to compounds of low 
hypnotiC value. The same findings were reported by Shome and Doran (1936), 
Tabern and Vol.iller (1936>.. and Buck et al., (19)e). :there 18 some indicatior 
--
that. tV alk,yl derivatives can increase the convulsive p1"Operti. of barbituric 
acids cont&in:1ng six to Beven carbon atoms on the fif'th position.. In this 
respect, S-,-(l,J-dimethylbutyl) methyl barbituric acid can be given in dosage 
of 170 ",,/kg without pl"Odaction of convulsions whUe ita N-meth71 and ethT1 
der1vatifts produce convuleions in the range ot 7-15 Jttg/kg. Henae and 
Spurlook (19L1) prepared a eeries of N ... aubatituted phenobarbital derivatives 
attaching the follOWing groupe: preplonyl, IB-hydl'Oxyethyl, ~chloroe'th71, 
phen¥l-phenacyl, J)henec)"l, p-b1"O!'!tophenaeyl. The majority ot theee cO!I1pOUnde 
showed 8i ther very weak or no hypnotic activit)r but at the sa-me time demon ... 
strated increased anti-convulsive p1"O!'ttrties. Sandberg (1949) prepared 
N-C}{ COOC2HS' S,S-aJJcylal171 barbtturic acids, finding that they weN ultra 
short active .. 
'Rush and Butler (19)7) propnred a series of tetJ"aJllkyl barbi turio 
acid (dimethyl barbital, -lpraI, -dial, etc.) and noted the following proper-
ties t they wore short lasting and fut acting and requ1red 8""8l.1er d08es than 
did tt18 parant cOIIIpOftnds. Their nction varied f'l'tIm pure bJpnollia e.g., 1,)-
dimethyl 5,S-dim.et1"1' barbituriC aeid to pure convulsive eftect e.g., 1,3-
dimeth,.l, $,S-dlallyl barbituric acid. Sandberg (19$1) stated that the hyp-
• 
notic action is probably based on the free hydrogen present in the barbituric 
acid which, he believes, could interact with protoplasm. According to him, 
the di-ni trogen substituted barb! tunc acid should be ina.ctive. He prepared 
1,.3-CIU"bo~thyl, 5,5-di&117l barbituric acid which did not t;'lhow any hypnotic 
properties whereas its m0l101ubstltuted analogue wu fl1pnotic. 1he difterence 
between these ruults arri those of 'Bush and Butler (1937) could be explained, 
aCf'Ording to Sandberg, b7 virtue o·f the fact that the N-dil'leth71 compound used 
by Bush could act as the dellteth.7lated product. F.!Ven so the anthor doubta 
seriously that the obserftd fast action of this group ot OOl'!lpOUnds could be 
po8alble it aome metabo.llo processes are required beforo they aro aotive. 
(h) Substi tutiona on Carbon 7Wo ina Phamaco1og1eal. 
Action. 
'1'abem and Val willer (193$) reported that the thiab&rbltu!"ic a.cids 
proved to be tuter and shorter acting than the parent compounds. According 
to ~an.Oll !l !!,., (1916) the sulfur analogues of barbituric acid otten in-
duced P1'8- and postanesthetic tremors, convulsions, or even convulsions alone 
wi thou t Pl"oduci~ Clt:tS thesia.. Even 80 the SllJ"V'iVal time vu shortened if con-
wlsant thiobarbi turate was admintstered along wi tb the lethal dose or a c0m-
mon depressive barb! tun te. 
A different t)tpe ot barbiturate acid de!"ivative 18 represented by the 
recently introduced ant1eonwlaant dru.g myaoline which has a fully 8a.turat~ed 
p;rr1,mldlne r:tng - carbon two contains two hydro~en atoms instead at the usual 
oxygen. atom. 'Ibis drug proved to be a strong anticonvulsive and weak ·h1Pn0tie 
r-. 
I 
The sarno C'lOt!!pound 1ndieat88 that no freE! H ions are neeos~;ar;y for the pharma.-
eological actin V of the barbiturates. (Sexton, 19$.3). 
(S) The Relation Bev,f€et1 Hypnotic and Anti-
donwlsant ActiviV. 
'lbe previous dlscuE=sion dealt mainl". w1. th the rea tion of structure 
and hypnotic actin ty. There are few reports which have tried to relate the 
hypnotic and anticonvulsive actiYi ties_ 
FYerett and Ritbard (19L5) showed that S.S-d1meth7l barbi tunc acid 
had neither h;ypnotic nor anticonvu.l&a.nt actirt V whereas 1,S,S-t:r:!.Jtetbyl 
barbiturio acid proved to 'be hi.gIll)' antieonvul.8ant Without any sedative 8ide 
effects (?<fAD over 1 gM/lcg). 'With I-meth,yl, S,S-meth,yletby'l barbituric 8.e1d 
the hypnc,tio properties were not evident and it wu still effective as an anti-
convulsant without sooation. lb. l-methyl, ,S,S-d1ethTl barbituric •. cid wu a 
!'!lOre powertul h1Pnotic but it va also an effective antieonwlsant in dos. 
producing ata:x1a. S,$-dierovl barbituric acid was a eentNl convulsant and 
also an antieonvulsant against metralc!. :the higher saturated aliphatic com-
. 
pounds showed powerful hypnotic properties but relatival7 poor ant.1convulslll'tt 
aet1'f'1v enm in doeu causing sedati.on and ataxia. Cohen (19h6) described a 
series of $,S-alkyl th10etner barbituric acids with just the opposite findings 
to those of rverett. He found that the 1nc~e in the mtieonvuleant acth1. t7 
was direct proportional, in this group ot oompounds, to the nUJ!llber ot the car-
bon a't'.m.ss in the side crain. 
Allee !l!!., (19h7) stated that the anticonvulsa'l t aetion of a drug 
mq !nvoln a mechanism which increasee the ~istance t.owarda irradiation of 
motor discharges and does not necel:l<sarily involve depression of higher ne". 
centers. His findirlp's supported this view. S,S-phenylbut;yl barbituric acid 
showed only one third ot the hypnotic activiv ot S,S-pbenylethyl barbituric 
acid but the first substance i8 superior in its anticonvulsant activiV. That 
the basic struct.ural mechanisms for the anticonvulsant and hypnotio action are 
not idf.mt:lcal or interdependant i8 Ulw;tr&ted by tho simultanaows presenCE! of 
tbe ~ot:te and stiMUlating properties ot !>,5-bt:,naylethyl barb! tunc acid.. 
'lb. presence ot Olle phenyl group iEl necessary in $,S, disubetituted barbituric 
acids for t.he 8t1tlcvmsulsive properties but tho presence of dcuble phenyl 
[grOUPS C&Uf!!. convulsive activi q. 'lhere i8 apparently a maximum of this anti ... 
convulsant. aCtiVity in the S.S-pheny1bu~1 bl!U'bitllJ'ic acid lihUe t.he branohinge 
'rJt ttw Ivaight chain decrease it. In a stud;r ot the analogues of the unaatur-
rtted serJ.es (Alles et al.., 1949) it "'''1All round that the W'lsaturation did not 
--
ute1" the anticonvulsant aotiv1\7 but the hypnotic and lethal actirtU. 'Wel"e 
reduced. 
(6) The RelativltT of the Stimulantt and Depress!ve Actions 
t Barbiturates. 
Tn discussing the depressive and comul81ve barbiturates one has to be 
'8%)' earetul in eftect.mg ll.I"oper usage of these terms. It was shown by' Swanson 
fnd Cben (1939) .. Fuhman !! !i_I (191.1) .. Knoete1, (191t5), i\idlard (19Sl), that 
beee propert1(;'. are relatlve and depend in 80Dle degree on the me1:bod ot test-
~g and the apecies ueed. SWanson inC;' Chen (1939) confimed findingS ot 
}rt0efel (1936) that S,5-(1,J-diMetllylbuty'1) etJl;yl barbituric acid is convulsive 
r 
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in warm blooded animals, but be showed in addition that it is depressi" in 
cold blooded alimals and gives an adclitive effect to the lethal! tv of 81'!\Ytal 
in yam blooded animale. furtherMOre, Fuhrman et al.., (19!U.) pl"O'V"ed that it 
. --
is able to depress brain oxygen uptake, as the COl'l'I."lOn depressive barbituJ'at,8a 
do~ Knoetel (191,:S) OO"lJ'ared the 4etion o.f' dU"f'erent barbiturates on the 
spinal dog and the :tn tact an1.ma1,. He found a similar! t:r in the stit!l1lAting 
action in both Mimal preparations "'lith S,,-(l .. 3-d1methylbutyl) ethyl barbi-
turie acid and ",-(l,3-dimethylbutenyl) '!I'Iethyl barbiturie acid. FWn so, 
while ,,5 .. (1 ethylbutenyl) ethyl barbituric acid and S,,-(l ethylbutyl) ethyl 
barbituric acid were cOn"IUlsi". tn rats .. thes., compounds did not markedlT at-
feet the flexor reflex in the dog. 'lbe thlobarbittuoates ar€ .trequently stbtil-
lating while the bO!!tOlogolls ox;:ygen barbiturates are deprusi".JI bu,t when the 
omen derivative 1s already highly stimulant e.g. $,5-(1,J-dimethylbut;yl) 
etbyl barb! t~lrl (! IJoid the au'b8t1 tution ot sulfur on carbon two abolishes the 
st1T1JUlating action in spinal dogs 'While presening it in the intact animal. 
Richards (1951) studied the convulsive thioba.rb1 turates in three different 
speciest T!IO\lSe, rabbit, and !'IO!'lke;y. He found that rabbits have the great.est 
. 
tendency to re&et eonvu.lsively, mice seoond, and l'lOnkeys the least. A gr'(;at 
majority of" th~e c01'l1pOtmds although convulsive in rabbits wore h)'pnotic in 
monkeys a'1o the results wi th metl'asol in mouse protection tests where subcon-
vulsive doses of: t.h1obarbiturates ga.w protection against metrasol convulsions, 
1f~re in good agreement ,.,tt th "su1 ts in monkeys. !t foll0W'8 that all of" the 
th1obarbituroatea investigated poseeased some sedative properties wbich would 
not be obvious it only certain species or methods would have been applied. 
"..-
I 
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Even the compounds causing convulsion in monkeys produced sedation if premedi-
cation with small subhypnotic doses of pentobarbital or morphine were used. 
'Ibis proves that certain "convulsant" thiobarbiturates also possessed a 
hypnotic property. 
B. Methods for Study of the Anticonvulsant ActiTity'. 
'!be followlng discussion will give an account of the methods of 
sCl"e9ning po ten tial anticonvulsive drugs. bse tests can be divided con-
veniently into the fbllOWing groups - (1) electrical stiimulation methods, (2) 
pharmacological. stimulation methods, 0) experimentally induced stimulation 
foci. 
(1) Electrical Stimulation Methods. 
The following historical discussion is based upon that given hT 
Toman and Goodman (1948). lhe first attempts to study the drug effect hT 
electrical stimulation were those by Arbertoni in 1882 and Bilaeles and 
Zbysaewski in 1914 who used faradic stimulation of the cerebral cortex through 
the trephined skull emplOying a relatively prolonged stimulation of thirty 
seconds. Schiff in 1922 adopted JelUnek's (1920) method using corneal eleo-
trades and measuring the seisure threshold for &1. ternating currant applied· for 
o.s second. Spiegel (19.37) also used corneal electrodes but measured thres-
hold with both time and intensi~ as variables expressing the threshold in 
ampere - seconds. Merritt and Putnam (19.37 and 1938) applied rec·tB.ngular 
pulses of direct current for 10 seconds through skull and mouth electrodes. 
Alles ~ !!., (1947 and 1949) employ-ed alternating current of fixed strength 
~o that shock duration rather than current strength was employed in their 
18 
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determination of threshold. Barany and S tein-,Jensen (1946) passed al. temat1ng 
C'!!l!"'J"'ent throur,h the electrodes placed in the extemal auditol"7 meatus and in 
eontl'Ut to previous wrkel'8 detemlned the erfects ot drugs on seisure thrt~­
hold for both long and short pel"1.* of stit'llllation. In additiDn they ob-
served the effect ot the drug on 8f1izure pattern as well upon aeiau1"e three-
hold. Taman, Bwtnyard and OOodman (191",6) also directed attention to the 
effects ot the antieonvule8'lt agents upon se!sure pattem e1iei.ted by supra-
maximal shookS md introduoed an assay' t'Ilethod based on their ob3ervatione. 
Clinically established anticonvulsants (dUantin, phenobarbital) have in 
COlI!!!!On the abUt t)" to aboUab the toni c extensor COMponent it a max1mal 
seizure is pZ'oduced by eupram.ax1ul shock. 1b1a property is particularly 
significant with respect to dl1antin which is ineffective in al ter.1ng the 
no mal electroshock threshold or in protecting against the usual convulsive 
do~e of metruol. 'lbe results, therefore, suggest the poBBibility that the 
efficacy 0.1' clin'Teally etteeti'l1'e epileptic agent ma,;r be better eorrelated with 
a reduction in abilit)r ot the brain t.o support selt SUflta1ning discnargea than 
wlth a simple inel'P ..... 1n tbe electrical and chemical threshold tor initiation 
of suob disehargee. In addl. tlon, not all investigatoN are as-reed that 
electric shock seisure threshold in epileptics is abnorYllall.y low. (Kalinowsk;y 
and Kennedy, 19113). Toman, Loew. and l100dman (l9h7) exter:~dod this method by 
studies on the «".etten ot druga on the seiaUl"e patt.ern in nomltpileptic psychoti 
human patients tmdergolng electroshock therapy_ It W88 observed and confirmed 
that the prttients p~dieated 'Wi th dil.antin have a greater than normal in ... 
• 
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cidence of atypical sell1ul"'U. There was shortening or even aboli td.on of the 
tonic phnse ot seizure by dilant1n end mesantoin. Toman and ("JOodman (l9la) 
criticized t1H~ oririnal Putnam. and "!ern tt Mthod for detem1niny' thr~hold 
ot minLlIlal seizures because of the long period of stimula.tion used. In trying 
to dup1.icate exactly their l"88u\ts they round that dilantin effectively short-
ened the l'I'I.8X1mal duration of seiaure produeed by prolonged stblulaticn eo that 
tonic clonic activities ha'ft ended before the stimulus was t)ver. '.£heretoN, 
they used brief shoeks (0.2 aeeond) in order to permit observation ot seizures 
throughout their entire course. l"urt.~ez-ore, since a drug MAl' a.l ter the 
character or seillures the,. tou.nd it 1.8 1~r'tat'lt to take as a threshold rea-
ponse the minimal. selzurea (tooal and li!1'lb clonus). SWinyard, Toman and 
Goodman (19116) introduced the techn1que ot artificial lowering of seizure 
threahold b7 hydration ot apertmental anillals in order to stuc.tf the pl"Otectlv. 
action of antieonvulaant d1"'Ug8. 'Ihls method was of particular interest becaUE!4 
dilantin vas able to raiBe the convu.l.sift threahold in such an animal. ',roru.,n 
(1951': described a new technique ot etiJ!'IUlation using a current ot low tN-
quenq. W1th lower trequenq (e.g. 9 msec rectangular puloo., five to six per 
second) it beC&1'l\e increuing17 dU'ficult to produce seillures having a tonic 
phase. '!here was littl@ evidence of. nelll"Ologieal depre3sion euring clonic 
seizure. The tHtl.urea weN usually lim! ted to the tAce and fore~t, allowing 
altemating allwmatiam resembling th~ pal'chomotor a.ttack. ;,t was E'Uq"Alcted 
tha t. this might be a s1»oU'10 test for the pot-ential anti ... ps;rchomo·t.or drugs_ 
Tverett and TOl'f1&l.1 (19,1) found that ph~:,;nurone 'Was verjl' orrectJ:v(l in raising 
the threshold w.l. tbout any deoref3sive s.ide effects. rYerett and Richards (19$2 
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were able to show that phenurone was not onl,y able to rau.e the threshold 
but also to modif.y the usual pattem of eeiSUN. Goodman, lOman and Swtnyard 
(191.&6) tried to correlate the antiepi1eptic action ot the drug wi th ita abili. 
ty to aboliah the <onwaold activity ot brain but were net sucoollsfUl. 
Tr1dione and phenebarbi tal raised the threshold ot current necessary to pro-
duce El'O convul81ye pattern but prevented H:(} discharges only in toxic doses. 
Hhle1don and van Hanevelcl (19$1) could not find 811'1' eftect on conwaoid act!-
vlty for trld10ne whereas phenobarbital. vas quite effective. They concluded 
that the lack ot such correlation may be indicative ot a diffeNlce between 
convulBoid activity and the EF(l equivalent ot the epUeptio seizure in spite 
ot the other apparent resemblance. The only !2. _vi_tro ........ l"'l6thod developed to 
test antiepileptie activity ot a dru.g is on the sciatio nerve preparation of 
the frog. ('Ibman and Hendley, 1941:). 'lb. effect ot a drug 'Was deten1ned on 
the excitability', action potential, ooruhction velooity, et.c. It was found 
that dilanUn prevented the appearance of double action potentials atter ex-
cessive stbtulaUon. But it. 'Was w1:bbout any effect on the throshold of the 
stimulus whereas other drup such as mebaral., phenu,ronet mesantoin had this 
effeot in addition to the first one. 
ReCOl'!ll'ltendati.on.a uaetul. in planning slJoh experi.ments are tound in 
articl_ by 'lbMn and Goodman (1941), Ewinyard (19k9), S1t'inyard et al., (19S2) 
--
'Wood.bur,y and Davenport (19$2) .. 
(2) Pharmacological Stimulation t.(ethods. 
'1bman md Ooodrttan (19Ltn gave Aroortoni (llW2) credit for the first 
atte~ts to analyse the effleaC:y ot an anticonvulsant drug (bromide) using 
r· 
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convulsant agEnts. T..andols 1n 1881 applied creatine to the cerebral cortex 
of exper:imental an11!lala in the earliest atteropte to produce local "ei.urea. 
Buglioni and !"agnini in 1909 introduced topical application of str;ychn1n •• 
Before the advent ot metruol auch preparatiorur as t.bujone, homocampin 
(Lennox et al., 1929), abe1nth (Hlsberg and stookq, 1923), were ueed to pro-
--
duoe convulaione. But aooording to Putnam and Merritt (1937) these methodS 
were va". drastio and. were llla8u1table p1'Ocedurea tor stud;y.lrlg the faotors 
which mq ettec\ the ocOUl"l"8nce of the sei.urea in patients. Recent uaage of 
cOll'VUlNnt dru.~. in laboratOl7 ustq 113 exemplified in the 1f01"k8 ot EveNtt 
and Mobards (1944), Fwrett (1946), ("JOodman and Toman (191.6), 000<i"'l&n, Toman 
and. S1dnya.rd (19h6), S1dnya.rd (1947), Chen et al., (19$1) and. man;, othen. 
--
The above authors used the aubcutaneous route ot adm1n1llltrat1on of 7$-90 mg/kg 
of _truol, as a result. of which the animals without p1"'8m4!Klication would eon-
wlee. If the premedicated animals failed to haTe sei.ures a second group 1.1 
giTm a higher doee ot _tolUOl. rus procedure 1IU repeated until the dose 
ot metruo11l88 attained whioh produced Wical convulalona. In this lf8.)" tJut 
tlegree ot protection <_truo1 antagonism> tum1shed b1 a drug in question 'A'l&7 
be asoertained. A d.itteNlt. _thod 'U8ing met.ruol vas described 'by Orlott et 
-
al., (1949) _ere metruo1 waa injected intravenOWllyat a definite rate and 
-
the animal.e were ob ..... ed 1I1hUe they "ere being injected. The patt.em of 
aeau,. and the death pictures .. re well defined in the untreated alimal grou 
eo that. compari.8ooe can 'be Jll.8de with the treated group. lhe elevation of the 
dose ot _tNSOl over the o:mtJ'Ol level required to produce various phases of 
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oonvulsions is taken as an indieation of the protective action by a drug. 
According t.o Orloff et &1., (1949) this method presented distinctive advanta;: 
--
over the subcutaneous metruol teet such in that.'. (1) fewer an1mala are re-
quired to get signifi(,Ant reeults, (2) leas time is neccs58l7 to cO"ltPlete tea 
ing and (3) it is &q\14l :in accuracy to the subcuta.neous method. 'lhle method 
will be used in the SCre0.L"ling work: to be presented in th1e thesis. C*rOOdman 
et &1., (1953) introduced a ItMaxi.m&l l~etrazol Seiaure" method. The mouse is 
--
injeoted intravenously with a .fixed dose at metruol a.."ld observed tor the 
appearance and dul"8.ti.on ot convulsions with tonic clonic coPJPOnents. The 
Mouse was considered protected if anticonvulsant drug prevented the appearance 
at the hind leg tonio extenaor component ot the seieur-e. c.oodman did not 
reeonnnend this method &8 a useful asaq proceaure beoause the lIlort.atH:.y wu 
much higher than after maXimal electroshock threshold and it was More dirri-
cul t technically. 
The fact that MetraMl in 8ubconwls1:V'e doses is able to produce 
characteris tic nn al tara. Mons (8 traus and P..ahm. 19.39 J navis .rmd Sul.bach" 
19bo, 'lbman and Davi., 1949) 18 used for assaying the potential of antiepUep-
tic drugs_ In rabbits. appJ'OX1,."IatelJ' one half of ClOnvul.s1ve dose of reetruol 
produoee d:fsrhythmias with etu.;raat~riHtic smooth rive-second wavos ccmte.ining 
spikes (Iimllar picture ,t4 petit mal. fm). If a lllr~~r dcs($ if: f.1ven tbe 
801su.N8 are heralded by the appea:,anco~r g:t'01.1pe or high. voltage spikes in 
the motor cortex anci is usociated wi th clo!lio:1Kn"9manta whiC'h are f'ollowed 
by clinical and FItl tonic clonic Se1&UN. It w~s shown that tr1dlone i8 par-
4 
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ticu1ar17 e~feotive in prevention ot this abn~mal F.FO picture. This tr1dione 
speeif1e1 ty 1& well correlated wi til 1 t8 c1inica.l 'Value in petit mal. On the 
other hand the barbiturat. do not mow such a selected actin ty on Ute Ern 
pieture (""'an, ooodman and SWinyard. 1946). 
'lb. other recent report on pha!'l'l'l&cologteally induced sei&ures 18 
that by Anderaon (1949). He succeeded in producing conwlalona by injeet.1ng 
acetone into the cerebral cavit7. 'lbe acetone 888mB to produce oonvuleiona by 
dissolving brain lipoid material. Chenoweth and John (1947) 8TOked FEG d,;rs-
rbythmiu eiillar to the petit mal pattern by inJection ot fiouroacetate. 
'lbeee dJ'arhythmias were inhibited by barbiturates and trldione. These two 
"'I8thods art"! not used in assaying procedures. 
en Expenmentall,y Tnduced ~tiMUl.at1on Foci. 
ACCOrding to '[oman and OOOdman (19L8), Speransky in 192,$ introduced 
a method or tocal treeainp or one cf'rebral hemisphere to produce epUeptogenic 
lesions in dogs. This method 1fU later adopted by Keith in 1944. Kopelotr 
and Barzera (19b2) produced chronic brain lesions by inserting linen disea im-
pregnated With immunological and chemical substances. The blplantation methods 
are not widell' used tor assaying antlep11eptic drugs but they are useful for 
stud;y ot experimental epUepe7. Johnson and l.talker (19$2) shoved that the ex-
penmen tal toci have a much lower threshold tor l:;EQ changes induced by metruo1 
~ 
C. BiOchemical Aspecta ot Barbi tura'te Action. / 
(1) Barbiturate and Ena,me Interaction. 
The work ot Quaatel and Heathl. (1932) stimulated res(lareh pertaining 
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to the act.1on ot barbituratea on enzyme syste!rra. '1bey observed that narcotics 
in gtneral inhibited Oxy'gen uptake tv brain and other tusue. !!!. vitro. Their 
results were oonfimed by' numerous workers (Michaelis and Quaetel, 19h1, 
nrieg, 19L6, 1947, 19$2, Penky fit 41., 19$0, WEStfall, 1949, 19$1). 
--
'lbere i8 little doubt that one of the poeAib1e ways in which barbi-
turates produce their pharMacological effect 18 by inbibi tion of the oxidative 
processes. But the question arises as to whether or not -this i8 the chiet 
Mode of action. It can be indicated now that there is some experimen tal ev:1.-
dence which S:!OWII that there are other mechanisms ot action. 
Orieg (19h6) gave a good historical background ot the work dealing 
with en.,. and hJpnot1c interaction reau1 ting in decreased oxygen utiliZAtion 
Kellin (1929, 1939, 19110) in h18 elusiea1 work on the cytochrome& found that 
b 
narcotiee (urei:..llan4 HpeciallT) prevented the oxidation of cytochrome/ by other 
compon~ts of the eytoclll"'OM S78tem. He suggested that the effect of the 
drugs was brought about by the :fbmation ot a relatively stable complex cam-
~sed of deby'drogena.se, substrate and cytochl"'Ol'd. Jovett and Quutel in 1937 
u8ing ether, eh1oretone, and enpal found that certain OOncm trations which 
marked~ inhibited oxidation of glucose, lactate, and pyruvate had no effect 
on the OXidation of succinate and p-phenylenediamine. ~inoe in the Oxidation 
of succinate no coenZ1l'M~ are required and hy'drogen is transferred dlrectl¥ 
by means of 8u~c1n1c dehydrog8n'se to the cytochrome system, the absence ot 
the effect by narootics on the oxidation of this substrate indicate. that the 
cyt.oehl"'Ollle qatem or tha.t part of it involved in the oxidation of succinate 
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weB relative].,. resistant to nah a~~ntll. 'these Neults mowed also that. the 
deh7drogenuu were relatively ineensi tive to the action ot h7Pnot.1c drugs. 
!41,chealis and Quaatel (19hl) narrowed the narcotic sensitive range to the 
regions r("precented by 1 ani II below (nreig, 1946): 
Narcotic 
1nseDlft1 va 
region 
Narcotic 
insensitive 
region 
Narcotic 
insensitive 
region 
It inhibition occurred at I we would expect the accumulation of 
the reduced oo.,. .. e (~ I). '-'his 1s not tound. lhe b10eldng 81 tit 
would then be at II since we .lcnft that debJdrOgenues am their reactions wi til 
cytoohl"Omfts are relatively insen.,l tift to barbiturates. artGg (19h6) sugeeste 
therefore, that the narcot.ics 11&7 aet by attaching to the reduced flavoprotein 
cytochrome b (or other 1ntem.ed1at.e) complex. Perukey at al.., (19$0) tried to 
--
prove that pentobarbital blocked the !lYNvie 4cid oxidase systerll most like17 
at the os1dat1.on ot tvo carbon fra.gment8. He postulated that the critical 
sulf'hydry:l groupe in the J)7PU."1ic deh1d1"Ogenase systfn were the barb! turate 
~ 
I 
... 
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sensitive molt1&e in the ox1dative mechzlism. a"" Grieg (19$2) could not 
repeat. the work by Pensq and,. thorefore, it seems that the present opinion 
is '!hat the flavoprotein and cytocllrom linkage is the barbiturate senei Un 
The Question arisee as to whether one can explain anesthesia in vivo 
--
on a basis of' the results !!!. v1t~ wherein the depression of' ~ uUl1u.tion 
vas the chief ttnd1.'"lge 1'he follONing series of' observations ahov that the in-
hibition of oxidation Eer !! 18 not an ent1re~ satisfactory explanation of 
harbiturate action. (1) The brain f!\etaboliem 1s not depressed ira vivo until 
--
deep lew1s of anesthesia are attained but much !\motional. derpl"8ssion i8 at-
readT obso!"led (Bain, 19$2). (2) 'lbe condUction through ganglia 18 depressed 
with no change in ox;ygen COJ1a\lJlPtion (Larabee et al., 19)0). (3) tow doe_ ot 
--
barbiturates !!!. vit~ stimxlate o~gen consumption (Weatfall 1949, 19)1). 
(4) '!he convulsive barbiturates inhibit the brain ox1.da11on in 'V'itro (FUh!"!'l!an 
---
!! !!.., 1941). (5) 'the fif'V per cent ()2 coneumpt1on inhibition doH !!!. vitro 
is _eh larger than tile fifV per cent anesthesia dose, which 1& calculated 
on USUlllPtion of the equal d1etributton of drug atter adMinistration (Bain, 
1952). 
One possible e.xplan.atton of the above described phenomena is a postu-
late that an alternating pathwlr tor glucose oxidation exists wh:i.eh is direct-
ly concerned with function and which may ~! conceivably MON sensitive to bar-
biturate action. '!here is sonte evidence for an altema.ting pathway but the 
experimental SUbstantiation of this h)'pothseis 18 not ve17 extensive (natn, 
1952) • 
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Tt is knoNtl that certa:ln chemicals call interfere wi tb the coupling 
,rooolin~. Mid allow oxidatlon to proceed watetull;T in the .«Inse that no 
about another pOfJt!1ble site of 4\::tton for barb1t.uro.tea .. na..ly 1nterfer~ue. 
,,:th these eoup11n~ and transferring mechanisms (Ba.1n. 1952). It has bem 
proved by f~ and nain (19$1) tba t thiQpental. per~ toharbl tal. and amobarbi t.al. 
loweNdtb.e phosphate and 0X)'get1 uptake ratlo of' a ep~elnl tis''nlo preparation 
respiring on P7Nvate. 'lhU depresllon vas obtained at the drug ooncentra-
tiona whleb had onl.J a Bl1gbt. effeet on 02 uptake and wbieb approsimated those 
rec:yt11red tor the 8nft8tb.1a in vivo. At this drug eone«'. t:ra~. on the uptake of 
--
:norganic pbospbatfll vas inhibited 1"01'4' per cent whereas the ~ consumption 
showed 0017 ten per cent inhibition. ¥lhen the upttake of 02 was still at fifty 
per cent or :1 ta normal control value the upW~e of' inorgardo phos~ 'hate was 
COMPlete17 i.."lblblted. Tn general the dosos requi.red to prcrduce fitt1 pel" cent 
lnhlbi tion of P uptake aN l'IIUcl\ 10\l.'er than thole prodtlc1ng t1!fq POI" efm t in-
hibition of ~ uptake. Ctne cz cunelude that the uncoupl1nr fdteet is caused 
by the action ot th~:!&e drugs on en~ S)lStemB Which are MOre sena! tive than 
'.'ihese o~orvnt10n8 G')u].d be used tor a p&rt1al Olq)larut1on ot the 
pbenOMena obsf!'Wd by woattall (19119, 1951) who round that small doe_ or bar-
bi turates at1T1'lUlated ~ uptake. "febb and rlliott. (19!)1) Ot}6(ll""ltf!iQ increased 
r--------. 
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g1ycoly'sis did not necessarily' parallel the co~pllng reactiOns. McLennan and 
:ell:l.ott (1951) dCMOOstrated that oorwentratioDIJ ot barbiturate which inhibited 
ihfil pncsphorylat1on si!'ltUltaneotWIy illlPaireti acevlcholine synthesis in brain 
which. required high energy pholJpha:~." as the energy source tor that synthesis. 
'lh:1s \fOrking hypothesis Qr the barbiturate action is not without 
critie:1sm.Bain(1952) .u~laed the main pOinte of criticism. It 1s difti-
cu.l.t to underst&.T\d in light of this hypothasis why barbiturates do not give 
rise to inorganic phosphatee !e. vivo. ACCOrding to 'the above tbeor.y dinltro-
F,hetnol l~uld be anesthetic because of its uncoupling ability. Its action ia 
<lust the reverse of thi.. In addition ver"J mqall dose8 of barbiturate st:blu-
lated acetylcholine synthesis and only larger amounts depress (Mc!..enna:n and 
BIllott, 1951). 
In eO'flcluaion one ca.""'!. say that there is no clear cut explanation of 
tile dIfferent effects on nervous function caused. by barbi tllrat..e action based 
on the availahle in vitro experimental resulta. Apparently some new mechanisms 
- , 
should be found before 001"1 could say .anything definite about the relation or 
the in vitro reau1te and experience in vivo. 
-. ---,--
(2) 'the Role ot Succin~te in Barbiturate Poisoning. 
The il'!petU5 tOf' reaeareh on the analeptic effeets ot lnlCeinate wu 
ven by the findings of 'lUutel and Heathle;y (1932). '.they found that 8ucci-
late oxidation vas not inhibited by barb1turawa in vitro. On the basis ot 
---
se findings Soskin and 'l'aubenhaus (19h3) tested the analeptic properties at 
odium rsuccinate, s!lotd .. '1g tba.t it was able to shorten the barbiturate anestha:;llt 
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time and reduee lethality rate, whereae glucose, lactate, and malate were 
wi thout any effect comparable to succinate. 
Repetition of Soskin's experiments was made by the following workers: 
Heyer and l.atven (19144), Finecmnldt et al. , (19LS), Adams and Larson (1950). 
HO'ltrever, the efficacy of succinate which they observed vas ot a le~Fer dep,ree. 
GUCeinJlte was able to shorten the recover,r period from pentothal anestheela. 
He expressed the opinion that. there is no doubt about the value of succinate 
aa an analeptic in hu.m.an beings_ 'in. first suece8s~11 clinical trial with 
sueei'o.ate was r~ted by Soskin and 'l'aubEmhaue (19tJ). 
On the other hand there are repOrte .howing negative result...,. f.ardy 
barbiturate anesthesia. Oowon at al., (1916) conducted ea..""'etul controlled 
--
studies without any positive results. Shack (19h9), uetnc rabbite, showed 
that succinate :In small and large doses did not sherten the duration of anes-
thesia. In addition he showed that succinate did not deereufit the blood and 
brain tissue levels ot barbiturates and did not aftect the rate of their excre .. 
t10n. 
'Ihe question meu 8$ to whether or not other CO'IIlpOnftnts ot the inteJ '"' 
Nediate carboh1drate metabol1n can affect;. the duration of lIOosthesia.. AdatU 
and I..areon (19$0) round that acetate bad even stronger anale'Ot1e effect than 
fJu~cinate whereu citrate prolonged thE! durat.ioo of anesthesia. Fumarate 
(Canon et al .. , (1916), malonate, j!'lutamate (Beyer and Latven, 1.91.1L.) did not 
-- ' 
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have 8.l'I7 effect. Although pyruvate (Westfall, 191,6) did not sborten total 
depressive tiM it did daCJ"eaee the depth of depression. A very interesting 
phenomena 't<mS observed b7 LM'IflO!1 et at., (1951) who observed that. the injee-
" .. ..,.... ....... 
tion of vartous CO~d8 including intemediatB cat'"boh7drate metabol1n 
products (sueein1.te too) returned tJI€! a"!i~l t.o sleep 'Idltl'l ~_tWtW eo~irtt" out 
of barbi.t'Urate anesthesia. 
'lbe e-.-<rlanations tbr 'the negative results ·0£ succinate analeptio 
action point out (L~.r'dy at al., 19h9) t~Hl't the orld9.tion of ttJceinie add 
--
was not couplf~d wi th phosphorylation which is the only known meeha..-"l.ism furnish 
ing energy tor animal.. Furcbgott ana Shorr (l9LB) ~tAted tha.t the extra. 
oxygen cOM'l:l1ltPt1on in the pr .. enco of succina.te was not ca.:pable of tncreas:tng 
the rate of the metabolic nroeessee depressed under t,onditlon& of low ~ 
tension. In fa.ct the increued 02 ccneu:mption b,. mlcci.yU'l~ depressed the oxi-
dation of normal substrates. \Iebh ~nd rlliott (1951) stated thtd, ellecin~te 
inC!"eued the 02 uptake by brain tissue eith(lr in the ,N5tmCS or absence of 
pentobarbital but did not suppress the inc'!"ea8cd lactic (~c1d producMon eatUl8 
by the presence of the drug. 'ibey eOl'll"1udeci th$t the~fl studies in 'Vitro in-_ 1 
dicnted the inability of succinate to reYel"afl the barbiturate errect. '!he 
claim that sucoinic acid can furnish nourishMent for a dw~ressed brain 19 
contradioted by findings of 'flein and Olsen (1911); succinic acid could not 
support bra:tn metabolism in the hypoglycemic sta-t,e. 
But there are some biochemical llnd ptlYSlologic.a1 fin dings which sup-
port t."1e role of fJucoinic acid a.s an a."1alf:ptie. -Wiler ar':d ~)~F\ren (191,~9) fOWl • 
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ful Em8rg}'" ''!!"ld(:!'' thf!!$e e{'ndUione. In exPeriments with anesthetized animals, 
Heymat\S ""irl tfaeol)s (191~7) ~howed that th.e in~eetion of 8uce1..'late atj.mulnted. 
re"lnUon an~ decreased the dUl"lltion of ,~n.ea l.1.::'ter l\YPerventilaU.on. It 
~ee'1!. that, the a.ction of ouoe1nate could be a direct effect on the r~fJP1!'at'<)r:f 
I 
#lpnea ,." not spee:t.fie ror ateeinie ad.~ beealUu!t NanCO.) end butyrate could 
f'lvoke the ~Si\me arfeete. 
"rtet" rea,'!lnr, 1',ha above review one i~ ~AHare of the complexity ot 
the prob],M. For thi. reason 80me work vae undertaken in. our laboratory to 
obtain Additional 1.nformatiM about this subject. 
-C!iAP1'J:'R It 
S 'lJ. ~ H T OF PROBLFM 
'the pr1ne1pal initial ob<j~et1ve ot the work done in preparinp this 
thesis vas to etud7 pharmacological antagonists ot the Ct'l'ltral. ne"oue system 
depression C8uaed by" selected barbi turs. te compounds. 
As the :1ntrOOucto17 stl1"'l'8y has indicated, there are several W&18 to 
ai'preach the study ot tbia probl_. It was decided that the author would limit 
hiS work to the following aspects: 
A. ~tu~ ot the etfect· that struct.ural change in the n1 trogen 
substi tution or the barbiturate molecule would have on barb! turate depres8ion. 
B. ~tud;y ot agents that might antagonIze barbiturate action by 
virtue ot rev('I!'fJing the effects or lowered levels of'metabolism due topCstu-
lated b10e~!eal lesions created by barb1 turate pharMaCological action. 
c. ~tud7 of the erreeta of. the highly sti:mulant barbiturates on the 
depress ion caused by common barb! tUN tea. 
Interest in the stud7 ot structural alteration or barbiturate nitro-
gen substituents was engendered in two ~~. Tbe substitution ot an al~l 
p,roup on the n1 trag-en ot morphine creat.es al171-nomorphine, a compound 
virtually devoid or pha.r'lll&Cological si?l'lilanty to morphine but which exhibitB 
a rather specific antQ.gonism tor the phantacolog1.cal action of morphine and i t.E 
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derivattves (Unna, 191tJ; Hart, 19L3; Huggins .!.:;. !!., 1950; F:ehenhotf !.1 !!,., 
1~2; Smith et al., 19$1). '1his eompound is now being used in a practical 
--
'Planner in the therapeutie revereal of Wlorphine depression. It was felt that 
the investigation ot the effects of analogCtUJ rompounds in the barbiturate 
series on barbi tura~...e i11toxl.oatton, should be carried out. There are indica-
tions in the literature t..'l-tat the substttut10n of larger radicala on the nitro-
gen atom can decrease the hypnotic acUYit1es at barbiturate moleculea (Shonle 
and r.oran, 1936. BIlek at al., 1938, Hense and $purlock, 1941).. It was aleo 
--
reasoned that these eompounds might be studied with a Tiew toward ascertai."'I.iIlg 
the efreet of a classical barb! turate an tagonist, such as metra.ol, on the 
action ot the altered compounds. Such studies would throw light on whether 
or not the str-J.ctunl alteration had conceivably altered the anticonvulsive 
properties of the moleeule also. 
Interest in the role of subs tar::ees capable of "by passing" biochtmlical 
Metabolic deticiencies postulated to ooeur &~ing barbiturate depreesi~l was 
stiMUlated bT the contraversies, which still eXist" concerning the original 
work of ~08kin an.d 1aubenhwa (l9L3). Ueing succinnte they ware able to 
demonstrate a barbiturate revereal in rate in vivo. "!'bey attl"ibuted this to 
--
the fact t.'1at slleei."late oxidat1.on cannot be inhibited by phtU'macologlcal aotion 
of barbiturate. in vitro. Hawe'f'er, the NGults of other workers in ViTO demon-
- --
5 tnt. eel no effect by 8ucclna te on barb! tUN te aneathes ia. ! t \>1M fel t that it 
ould be of interest to in'f'estigate this problem 1'urther in an a tteY!!pt to 
clarity some of the contraversial issues involved. 
--
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Interest in the role ot the stimulating barbiturates as reversing 
a~ents for barbiturate depression vas eti.Mlllated by the reporte of Knoefel 
(1936, 194$), SWan80n and Chen (1939), ~lor and Noble (19L9), Vellu. !! !!., 
(1951). '!bey demonstrated the existence ot antagonism between the stimulating 
and depressive barbiturates and between IS ttmulating barb.! turates and 1'lOrphine. 
Tn Ii, few of thece cases it was ascertained that tho stimulating barbi turatee 
acted syrmrgist1cally with classical bS,l'biturate depression rather than revers-
ing 1 t as would be expe cted. 'lbel"E:ltol.'e, 80me work was undertaken to clarity 
further the analeptic value of this class Cif compoundS. 
--
CHAPTFR III 
A. Materla18. 
'the animals used in all experim8rlts were Webster strain Albino mice 
of' both BU., weighing 14 to 20 gra.n'l8, obtained from Harlan Small Anintal 
Tndustriee. They were heal thy in appearance and had no observable physioal 
disabili tiea. They were red Purina Chow diet !S. _ll ... b.-i_tum ......... vi th tree access to 
water and kept in a well ventilated, air conditioned aniTMl room. 'lhey were 
aoeli~atl.ed to the new environmer. t for at le88 t two d8.1B after arM.. val ot 
ea.ch shiJ)llent bef'o" being used in experiments. The tood was withdrawn 8ix-
teen to twenty hours before starting any experiments, leaving free aoeess to 
water. 'lhese meuures vere taken to assure a more unitOI"l!! absorption :from the 
intraperitional in~jectton site. 
~. 
11. 
2. 
~. 
PHYSICAL AND cHi;nrCAL DA'1.l ON -00: COMPOUNDS 
SYN'l'fI1\TIZ}D Ul OUR LAflaRA '!my 
Dat.a or en ... ·ObS8rved 
Mole- A.nal.v8i8 )!felting 
CompOllnd cul.ar Fomula Founa caleuIa-
'Wt. N%* ted N% PoIntO C 
N-A~l 
i3arbltal 226 CIlOJN2H16 11.89 12.$0 77-78 
N-Allyl 
Pbenobarbi tal 273 ~$0.3N2Hl6 10.11 10.27 tX3.-69 
~-PbenAcyl 
Pbenobarbi tal 351 C200bNne 8.03 8.00 156-158 
H2O 
Saluhi-
l~W. 
Fool" 
Poor 
Poor 
*Pel"tomed by Dr. t. I. Dinguid, st. r .. ouls, '.to., using 'Miera Kjeldahl 
Procedure. 
3$ 
~ 
TA~LE IV 36 
I..15 T OF DRUG PRFt;ARAlInl 'iS US:ED .. 
. 
coneentra-
No. frtlg Preparation tion mg 't 'tA'ethoda or Pr~ara1iion 
"'I. Barbital C.P. 000 D18eolved in exoess of ':).l.N NaOIl 
neutralised \11th Hel distilled 
H20 q.s. 
2. Barbital Na U.S.F. 41fJ Dissolved in appropriate &mo' in t 
or d1etUled ~o 
'3. 5,!> \ J, j d1MCt.ny.Lal.L7.L \izUV'l. 250 
As in 2 Darbl turic Aeid Na~ til 
u. Metrasol, B1lhuber-Knol.~ 500 As in 2 
4;$. N-Allyl Barbital L{):), 800 A8 in 1 
I~. N-AUy1 Ph.mobarb1 tal bOO, 800 As 1n 1 
*7. N-Phenac;yl Pbenobarb1 tal. 5('0, ~()O As in 1 
8. Pentobarbital Na, Abbott 700,1200, As in 2 
1500 
9. Pl'lClObarb11iaJ. Na, U.~~.P. h40, tt$o As in 2 
10. Sodium Chloride U.S.P. 900 Prepared by compan7 (Baxter) 
.. 
11. Succinic Acid 0.1'. 170] As in 2 
12. Succinic Acid 0.,. 1700,6800 Dissolved in equivalent amount 
)L;)O ot N8OH, distilled H20 q.s. 
in ice bath 
13. SueeiniMide c. i .• 1700,6800 As in 2 
1lt- ea) ~alonic Acid C.P. )000 Roth acids dissolved together in 
(b) Succinic Ac':d C.P. ,31100 eqHivalent aMount or NaoH, dis-
tilled H20 q.s. 
15. (aJ Pentobarbital Na ~ (b} portion prepared as in lo, (a (b) N-AUyl BarbHAl portion added, distilled H20 q.s 
16. I a? Pen tob4rb1 tal N'a .,00 As in IS 
j b) N-All;,:l Phenobarbital 400 
11. l a) Pentobarbital Na ~ b) N-Pben~eyl Pbenobarbi tal 100 lJOO As in 15 
Note. (1) Drugs marked * were syntl'letised in our laboratory. 
(2) All drug solutions were pr~pared daily using the 
analytical balance and volumetric: 1'laska • 
..... 
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In 'rable III, compound (3) waB prepared b1 the author using methods 
dElscribed by Henze and r'purloek (19Ll). COI'Ilpounda (1) and (2) were prepared 
by T1r. C. D. Proctor. 
The syringes used for injections were I.Of) ml. tuberculin type, 
f!raduated at .01 ml. (B-D Yale 'fubercrulin, Becton Dickson ana Co.). 'lhe s1ze 
qr the needles was t,wmty-stt9'eJt gau~ fot" both intrAvenous 8.nd intraperitoneal 
injections. The devi.oe for holding th~ mouse during L~travelou. injection eon-
:,d.sted ot a (!One shaped holder Made of tnL"1eparent p1asUe, at.t.aehed to a 
lfM used to regulaw the injeottol"! '!"ate. The anf!!Sthetized l'!I1~e were kept :in a 
(1) Anti.convu1.81 .. Pttldieth 
'1his phase of til .. loW)rk onMiet(ll}O of two parts: (a) determination ot 
the phal'Maoologleal f.ltfeot o.f' Ott .. :c;yntheld.sed etmpOU.'1d8, (b) dete1'l''li.nattcn of 
the a'ltiCOTlwls1veactivi ty 01 our ~ds in comparison w1 ttl the parent 
compounde. 
(a) ~tem1rmtion of the PhaMaoologieal prfoets on CfiIltral. l~e~tl8 Sl!t.em 
t1he animal. wen injeotP-d by the tnt, ravenous l"O'!.1te with th!l new oolltpOUnds and 
Ithe results were compared with those obtained ;!n the Identic~'.l way 'Wi til the 
parent~. l'he CDlItpounda used W~"H (1) N-Allyl Barbital, (2) N-Allyl 
PhenObarbital. en W-Phenaeyl Phenobarbital. (h) P..a.rbital (S) Phenobarbital. 
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All were in eoo mg % solution at the dose US mg/kg. Pbwobarb1tal SodiUl Wal 
in 880 'IIIg % solutton tbich c01"'r8l!lponded sDpl"OX1J!lately to a 800 mg ~ solution 
of drug in the acid state. Its dose on the buia of the dI"Ug in the acid sta 
was 12; ~/kg. lb.. methode ot preparation of these so 1ut.1.one are given in 
T'd.b1e IV. 'lbe total doe. per animal was adjusted by varying the volme in-
jected (16 p an1mal reeeiwei 0.2; co_. 18 gil - 0.28 00., eto.). '1'be l08S ot 
the righting reflex vee taken 88 a starting point ot anesthesia. Following 
this the animal was laid on 1te back and the end point ot anesthesia lIU the 
time of reoovery ot the r1&bttng reflex. 'l'lle erteot ot our s1Ylthetlaed com-
pounde on pentobarbital aneeth.,ia was determined in the following 11&7. In 
the cue of test solutions the 100 mg % solution ot Pentoba'rbltal sodium con-
tained 1n add! tion the 1,\00 me • C<m.eentration of N-Allyl Barbital, N-Allyl 
Pbenobarbi tal or » ... Phetlae;yl Phftllobal"bi.tal. 'the control group reoeived a solu-
tion containing Pentobarbital lodium only. 'lb .. e drug solutions were injected 
1ntraperl tonea1ly at the following doses: Pentobarbital sodium 86 1Ig/kg alone 
or in combinatton with the other drugs whos. doe_ were ;0 mg/1cg. lb. total 
do •• per animal vas adjusted by val71ng tne W1UMe injected (16 gift animal 
recelyedO.20 eo., 18 gm .. O.22S eel. 
(b) ~tem1Mtton or the Antieonvulaant Activi!f:. '1he animals were 
divided into 1S-17 gm and 18-20 gm weight groups. 'lhe d1"Ug8 (fIT-AUyl Barbital 
~Allyl Phenobarbital, N-PhenaC71 Phenobarbital, Phenobarbital, Barbital) were 
administered intraperitoneally at doeu So to 100 mgIkg. 'lho total dose per 
animal was ad.1usted by v8l7ing the volUl'llGS injected (20 p1 an1m&l received 
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0.2$ eo., 18 grrl ... 0.225 cc.). All ani'ltals ware obeerved tor signs of depres-
SiOfh A $00 mg % solution of metrasol was used tor intravenous infusion 5, 
{fJ or 120 Minutes after administration of the test drug. lhe rate of infUsion 
I ,,<115 0.0$ cellO seoonds regulated by observing the stop watch. ill. reactions 
or the mouse to this timed intraverloua intusi,on showed a definite pattem and 
lias eimil:;1r to that described by Orloff !! !!., (19L9). 1'he signs of roeactlon 
followed each other in a strict sequence as th,g concan tratlon ot metruol Wl'lS 
gradually increased in the blood 8tre~. :the first ot these W88 the "first 
tm tch" - II; sham Single twitching ot the entire animal body'. 7h1s vas tol ... 
l~red "r,y shortly by "pseudoconw1sione" - a series ot clonic movemente usual 
11 accompanied by an audible squeak. Very often the mOllse pulled its head 
down under itl body. '1hese "pseudocorn .. "U1sions" were followed by altemating 
clonic mov&Y!ents and resting phaaee. 1he third sign a "persisten convulsion" 
appeared at tbe higbest concentration of metruol in blood and was the tinal 
end poi!lt of tne injection. It consisted ot tonic flam!" component followed 
by a usually lethal extensor cOJ!IpOnent. :"he author modified Orloff's proced-
ure by observing only tt:f':t.rst Mtch" and "persistentconvulSion" symptoms. 
This change was made because change. in the threshold of' the "pseudoconvulsionft 
followed 'l'8ry closely the changes in ttfirst twitch" thrt2!shold and because the 
latter can be observed With greater accuracy than the former. 
In determining the eftit":aey' ot the anticonvulsant drugs the eleva-
tions of t,.;'e metnusol 8oluti.on volumes required for elicl tin« "first twi too" 
and ":oersist.ent eonwls1on" were taken as cr! teria. lhe efficacy was expressed 
in the following value, oallecl the protective ratiot 
Protecti vo Ra ti~ ThrBShold after treatment, 
Norma th"rc:shoi<i 01 the corrElfSpond!ng 
control weight group 
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The ability of the drug to modify the character or the eonvu18ione 
(2) The narb1turate Reversal Studies wI th SUQcinic Acid 
and $,SO,.3-Di'msthylallyl) Ethyl Barb! turio Acid. ~ .. 
(a) ~he :R~iturate Re~ersa} l'y Succinic, A.~:ld and its Derlvati"! .• ~ 
In detHminat1.on of the etticaO)" of this class of compounds to re1ferse the 
depressive act,lon of Pentobarbital the hypnotic (88 mg/kg) and lethal (lSO or 
187 mg/ke:) doeM of the latter were admin1st..ered 1ntra;perl tonSAll.1. 'lbe com-
pounds being tested for antagonbtic effect on pentobarbital were injeoted at, 
the indicated doses right at the onset of anosthooia (succinic acid 212 mg/q; 
succinie acid 212, IJ24 and 848 mg/kg after neutralization wi th )~aOH, suecin1-
rtdde 212 and e,lt8 mg/kg, combination of Malonic acid 375 mg/kg and succinic 
acid L24 rtJ.ffftg afwr neutralization w:tth Na(lH). 1he total dose per mimal 
was adjusted by varyin.g the volume injected (20 g!I1 animal recelved 0.2$ eo., 
lS gm .. 0.22$ eo., etc.). The procedure for determining sleeping ti.M is de.-
cribed in (1)a. 'lhe lethality produced by Pentobarbital "'&8 expressed as the 
rate of survival. 7he control r,-J"Oup f'("ceived intravenous saline. A different 
approach to tne determination of any "analeptic· action of BtU-cinie acid vas 
tried by examining i t.s etfect on the metrazol convulsion threshold. The doses 
or the premedication were e4B mg/kg of' succinic acid (after neutralization) 
and 8uceinimide and the oontbination of malonio. and Buccinic acid 37$ mg/kg 
l4"ld 1125 mpjkg each (neutralized). All were adll'dn1Btered tntraperitontally. 
'Ihe tnt.ravenous infus :00 of metruol" performed as described in (l)b, followed 
in about five minutes. "lhe controls were animals wtthout premedication. 
(b) 'lbe Ana;e~t~c Act~on of ... 5,,?O!~-Din!e:th;Yla!lll) '-:t&l 
Parbi tunc Acid. A 2$0 lI'!g % solution was injected 1ntrawnoIl81;r at rate of 
0.05 oe/10 seeonds while making careful ol:'l8ervatl on8 of the animal. 'lbe done 
of 1,0 ~g intravenously of this drttg as a potential Ot"1aleptic was tried 
against the duration of' anesthesia and lethal effects ot Pentobarbital at 
doses 88 MP'ftg and 188 mg/kg, intraperttoneally.. The dotai.ls of procedure 
were the 5a-"'8 as in ~l)a and (2) a. 
-CHAPTFR IV 
RmUL'i'S AND DISCUS!3JON 
A. Anticonvulsive Studies. 
(1) Depressive Properties of the N-Allql Substituted 
?a.rbiturate •• 
'lbe .periments in this section wore designed to detemine any 
changes :in hypnotic activity ca.used by substitution on the ni tl"Ogen of the 
barbiturate molecule. Ofiginally, it was hoped that these new eomp01mds 'WOuld 
have a reversing effeet on the depre~sion ot animals under convent~onal barbi-
turates in a way analogo'll8 to n-allyl normorphine antagonism of morphine and 
many of its derivativeah ::ttl order tor this analo",. to hold in i tel enUreQr 
(a) very little phlll'!'llaeological effect would be e:<peeted to rewlt when the 
I'·I-allql eubsti tuted barb! turate. were administered alone, (b) no synergianl 
w:uld be obftervab1e bet'Hf'ert the N-GubGtit~uted and common barbiturates. The 
experiments designed to teet these two proporties are sumarized in Tables V 
and VI. 
'lhe results in Table V (page L3) indicate that the t~-f?ubl!!tituted com-
pounds used :tn the study were ohara.etoriaed by (1) ir1(~reased anesthet1.c power, 
(2) i:''ll'l'tediate onset or anesthesia, (3) short duration of aneetheel., (l.!.) short 
po8tan~sthetic depression. 
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TABLE V 
sr.ErPTNO 'rIME IWTfi'lr'TNATIOn OF N-ALKYL SUII:; TT'IUTFV 
BARBI'lURA'l'FS AND THEIR rARlmr coY.POmms 
',-. 
A"1I"erage TndUC- DUrat10n or 
:i:a No. of tion 'I1me. in Anesth8111a Compound . IV Animala ~cf1nutee in Minutes 
--
Barbital 125 $ None !'tone 
Phenobarbi tal US $ See Text See Text 
lW-A.11¥1 
BarbiiaJ. as S Immediate 
~-
L 
I-Allyl 
Phenobarbi tal 12$ .1 Immediate 21 
N-Pb.enaeyl 
Phent)'barb! tal l2S $ I_ediate 9 
The phenobarbl tal group did flot sholl aIl7 real G.."lesth.wu plcturt\t the 
anll!!1de lost and rega111M tbelr righting rona periodiea111 and exhibited 
prolonged depres.ion. 'lb. baPbi tal group va only madera te1y depressed.. 
'lhasa .n.ndinge with the N'"'8Ubeti tuted compounds were in good general &eree-
ment with the results obtained wUh the sane clas8 of oompounds in the WOft 
of rrox and Hjort (1927), 1ahem and Volwiller (1936), Shon1. and Do2'8ft (1936) 
Bush and FJut1er (1937), Btack et &1., (1938), Sandberg (19L9). fO!"te of those 
--
workers showed that the anesthetic power, comp:tred on a basis of minimal 
aneathetic dose, was either deoreased or increased. In the author'. opinion 
the route or adrrdnistration ean be an important factor 10 dete:rm.lning the 
relatiTe potency ot this elan of new drugs. ACCOrding to attler and Bush 
(1939) the initial rate or detoxification of these compounds ~ be futer 
tlllW the abeOl'Ption in the cue of routes ot adldniatratlon other than the 
tnt.ravenous route. 'lherefore, the more labile compounds would be !!letaholbed 
efore they can reach an etfective coneEn trat:ton the site ot action. '.!'hie idea 
~'!B.Y help to explain the conflicting reports on the rea tty. potency of this 
class of ~un&h Secondly, it could explain why N-pbenac;yl phenobarbital 
given tntraveoously ~)roduc.e4 c.omplete anesthesia in the authorts hands whUe 
Hen .. and Spu.rloek (19ul) did. not succeed in obtaining the ane.tbbtie effect. 
('nleir article did not state eloarly the route ot ad.'It1n1stration used but one 
uld Bum1.. that 1 t wu oral.). 
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TARLE VI 
1Mf: J.<F'r"rrCT OF N-AUn SUBS 'rt1H TfD HARSI'lUPJVI'FB 01' THE 
DURA nOtl Qf PFN'IOB.lHtl3t'mL ~l rs '11ffiSIA 
A'V'erage Inouo- Dura.tion of 
~. No. of Uon 'l"imo in Ancsthesia 1M IP Animall 'Minutee in Minutes 
Pentobarb1-
tal Na 88 10 2.$ 89 
Ptmtobarbi tal 
lila 88 10 2.5 IS1 
N-All;yl:J;uobi-
tal 
I Pentobarbi-
SO 
tal Na f\8 9 2.5 101 
N-A.llyl 
Pbenobarhi tal 50 
J)en toba.rb1-
tal Wa 8e 10 2.$ 82 
N-P~:u:.'m.BWl 
1~enobru.'b1 tal SO 
Notet In elCpfJrimenta marked .. both drugs were a&ti."11stered 
in the same .olut.ion. 
-----------------------------------~.--." .. 
-'lhe results 1.."1 'lable VI demonstrat.e a potentIating effect of the 
N-substltuted compounds a.t dose So mg/kg IP on the duration of pentobarbItal 
a."1csthpsia. Jbis dOBO when administered alone did not have any obsenable 
depreasive effects. The POtentiating e.ffect was ot varying magnitude! ~J.all,.l 
barbital ::thowed greatest 8ynergist:.c depreBs:l.v~ action. N-ulyl phenobarbital 
was or:ly s lightly synergistic, 'While 1!"'phenacyl phenobarbi t.G.l h&d ~10 effect 
fwh:!.ch might be due to its quick deetr.lctioll bai'ors it could l'a:;ach ,;frective 
eoneentratton at th6 site ot action). The d"'gree ot synergism to pentobarb1-
tal was parallel to the rolu.tive al'ltioolivulsive potellC:Y as. shown in. Table VII. 
as shown by llVerett and R1dl~1"d8 (19LS), Allee at al., (1947), Alles and 
--
F4.11s (191..\9). Theee L~vestigatol"8 conduced. a comparative study ot the h3P-
not1e and anticonvulsive propert1€<S findinf2; tllat increase in the hJrpnotic 
power va not always followed by' t.lle 8a.~ increase in the antieonvulsive power 
(2). Ant100nwla1ve Properties of the N-Altyl ~~ub ... 
8 t1 tu ted Barb! turatea. 
The above raeults 1nd:tcated thI.lt our s)'rltbetised COMpOUnds dd not 
have 8n7 or the expected analeptic properties analogous to those or N-allyl .... 
normorphine. Therefore, it 'Was decided to test their anticonvulsive potency 
in c»mpari8fm to that ot the paren t compounds. '1'able VII contUll8 the results 
obtained in the anticonVUlsive stud;y. As seen tram. TfJ.bl.e VIr the N-a.llyl 
barbital shoved distinctly different properties than barbital. Its initial 
r-
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'!HE ANTICONVur..sIVE POTFNCY OF N-ALKYL SUBS1.TIUTFD • 
BARBT 'lURA TES IN COMPARISON WI'1H 
THE PARENT COMPOUNDS 
DOse 1lSt. Protect- No. ot Persistent Protec- No. ot 
~ mg/kg Twitch ive an i- Convu1- tive Ani-[No Anticonvulsive IP cc Ratio ma.ls siOna cc. Ratio mals 
1. Control, 15-17 Om 0.13 1.0 24 0.L.2 1.00 24 
2. Cont~l, 18-20 Om 0.16 1.0 24 0.52 1.00 22 
N-A11yl 
3. Barbital, S min. 50 0.47 2.87 23 0.97 1.87 31 
h. 
N-A1J.yl 
Barbital, 60 min. $0 0.26 1.62 18 0.66 1.27 20 
N-Ally1· . . ,. Barbital. f:JJ m.in. 100 0.21~ 2.08 19 0.60 1.41 19 
N-lllyl 
6. Barbital, 120 min. 100 0.17 1.30 21 0.h6 1.09 23 
7. Barbital. $ min. SO 0.20 1.61 20 0.$8 1.36 20 
8. Barb! tal, 60 m.in. $0 0.27 2.07 19 0.69 1.6b 18 
9. Barbital. 120 min. $0 0.19 1.h6 22 0.65 1.5S 22 
10. 
N-A?-~I_ Pbeno-
barbital. $ min. SO 0.23 1.77 19 0.50 1.19 22 
N-j1 l.71 Pheno-
11. barbital. "' min. 100 0.31 2.38 2 0.77 1.86 U 
N-Allyl Pheno-
12. barbital. 60 min. 100 0.2S 1.8h 16 0.66 1.$7 21 
13. 
N-A?-lyl Pheno-
barbltal~ 120 JIlin. 100 0.16 1.23 19 0.h6 1.10 19 
N-PbenaC71 Pheno-
1h. barbital, 5 min. 62 0.20 1.$4 lS 0.$7 1.38 17 
N-PhenaC7l. Pheno-
1$. barbi tal. $ min. 100 0.18 1.12 19 0.72 1.hO 21 
N-PhenacylPheno-
16. barbital. 60 min. 100 0.14 1.07 17 0.44 1.0$ 18 
N-Phenaeyl Pheno-
17. barbital. 120 min. 100 0.12 0.92 21 0.39 0.93 21 
Pheno-
18. barbital, $ min. $0 0.22 1.)8 13 0.7$ 1.44 18 
Pheno-
19. barbital 60 min. SO 0 • .30 2 • .30 Ih 0.67 1.60 17 
Pheno-
l20. barbital, 120 min. $0 0.26 2.00 17 0.77 1.8) 19 
Protective Ratio: 'lhreaho1d atter treatment 
N'oi'iiiiI fl'iHisnola 0'1 correspOnding lleignt group (C<Ilttdls 
activit,. at the same dose u barbital demons trated a l"fIltarkable antieonwls811t 
activity both in raising the protective ratios and mod1.f)ing the pattern ot 
the eonwleion. The tirst twi ten and pseudoconwlaions were markedly ehanged 
to the extent that they were ditf'ieul t to obse"e. The other interesting 
finding vas the delq ot death after the development ot the ponsuten t con-
w181ons. More than halt ot animals shOWed this delay ot death and in some 
cases it lasted up to th1rv m1nut€tl. :Even so the lethal eon'lUl.sions were 
tonic fiexor-exten80r we just as in controls. 1he untreated oontrol animals 
died instantaneously after the appearance of the persistent eonvuleion'h 'the 
barbital eroup at the correeponding ti- interval (rive !'Il1nutee) showed emalleJ 
protect!" raUos and lea. &biliV to modi.t,y the metruel sei.uN pattern. 
'lbe ocourrence ot the delqed death vas not observed. At one hour post-
adminietration the same dose (SO mg/kg) o! N-al17l barbital showed a. markedly 
deoreased. anticonvulsive aet1Vity ..margas the act:tvit7 or the equal doee 
(,0 mg/kg) ot barbital roee in reepect to the protective ratios and ability 
to modtr,y seisure pattern although t.'1e delay ot deaths did not uccur. '.!he 
double dose ot ll-allyl barbital (100 "lglkg) proved to be 1I10re etfective at 
the oorresponding time interftl than the 50 l'Ig/kg dose 'but the protection 
arforded vas belOW' that obeE!l"Y8d at tift minutes post-administration and the 
animals showed a more or less t1Pleal sel.UN pattern. At two hours post-
adMinistration the activity of the 100 mg/kg !'f-all,.l barbital was more de-
creased than after one hour While barbital potency remained on the same level, 
as seen from the values ot 'the proteotion ratios and character of the comul-
sive pattern. 
-'lb.e description of the results and the data in the table points out 
that the N-allyl substituUon increased the imnediate antimctraaol act1vi~ 
of the parent compound but siMUltaneously decreased the duration of action. 
'l'he first property is in agrefIHnt with Toman and GOodrltan (1948). who stated 
that ~1-a1kyIat1on inereaau anUmetrazol aotivity. 'Prom these resulte it 
appears that the iTtmlediate metabolic product of H ... allyl barbital is not barbi-
tal as was reported in the ease of t(-mcthyl barbital which wu converted in 
ti;e bod7 into barbital (Butler and Bush, 1939). 'lbe hypothetical oxidative 
metabolic produot of 0Ul." co1llPOund could ha.ve the diol grouping on the chain 
of n1 trogen atom. if the degf'Qdation starte in this place. More extensi"V'e 
oxidation could pruduce 002 and a carboxyl group at the rest of the fragment 
on nitrogen atom. But other degradation reactions cannot be excluded e.g. 
tJU! stability of the barb1turate ring struoture mq be decreased b~' the pr~~s-
+ 
onee of the allyl radical on nitrogen in a wq analogOUB to the manner in whio 
the methyl radio&l on nitrogen atom deoreases the stabilit.y of the ring struc-
ture in alkaline solution (Butler and Bush" (1939). 
N-allyl phenobarbital at the same dose (SO mg/lcg,IP) as phenobarbital 
at rift minute post-administrat.ion showed interior activity with respect to 
proteot.i.'" ratios of the pe1"818tent oonvulsion. but it was more effective in 
raising the threshold ot the first -twitch" and "peeudooonvulsion". Both 
COMpounds were able to mod1.fy the first "tv! teh" and "pseudooonwlsion" making 
these erreets lees defined. '!be modifioation ot the persistent convulsions by 
phenobarbi tal vu JtUeh MOre pronounced than with N-aUyl phenobarbl tal. 
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l'h.enobarbi tal abolished the typical tonic con'f'4l.a:l.ve death by oh~g :I. t to 
the clonic type death which did not occur instantaneously. 'lbe larger dose 
of the n-allyl phenobarbital caused ve'1!'Y profound modification of the tirst 
ft twi teh" and "pseudoconV1.1lJsionstt so that only two an1ntls aut of eleven showed 
thane 81'l1Ptoma in any reCOgnizable f<)],"Il'l. 'lbe persistent convulsions, in the 
majority of cas., shoved a olon1c character which was especiallT well defined 
in animals dT1ng non-instantaneous death. The protective ratios at th1a dose 
(100 mg/kg I'?) were higher than those of phenobarbital at dose 50 mg/kg. One 
hour after administration with l~-allyl phenobarbital (100 mg/kg IF) there was 
a. marked decrease of the protective ratios and ability to mod1.t,y the character 
of the persi.8tent convulaiona. 'lhere was delqed death in three eases out of 
twent;y-one ani1ll4la. The pbenobarhi tal protection at one hour post-injection 
twas Incre.ed in comparison to ita l"!ftediate post--injeetion aotlv1't7 with 
ir-Pect to degl"H of convuleion modi f'ication and protective ratio. At tiro 
lOU" post-a.dm.1n18tratlon N-al.l71 phenobarbital showed a lower potene:y apparent-
rty affording only a very sUght protection as evident .:t.'\'o!'II low protection 
ratios and poor ability t.o IItOd1.t)' eonwlsion pattern. Jut the opposite piC-
t.ure was seen with the phenobarbital group whose protection reached a maxi:tnum 
at two hours atter administration. 'lbe percentage ot the delqed deaths 'WU 
Mgh, f'J..f'ty-oigbt per cent. The lethal convulsions were clonic in the majority 
':)f these pbenobarbi t.alised mice. 
From these reaul ts one m., conclude that n-alql pbenobarbi tal had a 
f'!Onsiderable shorter action than the parent. ~d qualitatively analogous 
...... __________________________ -...._,. ,""'-' -= .. ',~<I:"__,-J' 
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to the way in wbich N ... allyl barbital comparee.to barbital. 5uah ruultainrer 
the t i te Mtabolic def!'radation products were ditrerent f'1"D1'It phenoba!'bi tal whic 
ehowed a continuously increasing QC"tivi1:i'. lhe compound giving phenobarbital 
as a 1"i8tabolie produot 18 ~r..,...'t.h7l phenobarbital. 'lhis compound is converted 
almost quanti tave11 into phenobarbi tal in vivo as determined from the blood 
--
levels and the tissue coneentratione. (Butler .. 19$2). A difference between 
the t,",o &u,.1 substitutions in phenobarbital and 'barbital can be noted in that 
the N-allyl substitution of }>henobarbi tal did not increase the anticonwlsin 
propel"tlea or the parent compound a..C) markedly as did the chanv,e tl"Ot'll barb! tal 
to W-allyl barb! tal. '!he latter compound shoved a markedly increased L"iitial 
activity over the parent compound, but lacked 8USta1ned action. 
The resul t& wi th N-phenacyl phenobarbi tal at 62 mg/kg dose fiTe 
Tllinute post-adnd.nistration indioated a moderate protective action and poor 
ab1liv to mod:tfy the convulsive pattern. With incre"'l.sed dose the protective 
ratiO did not be0Q!i!t8 higher but a very pronounced ability to change the lett-.al 
tonie convulsions to clonic tJpe wss observed. nelqad deat.h wea obaerYfHi in 
seventeen out ot went,.-one animals. 'Ibis delay sometimes r"oached thirty 
minutes and several. eelSUJ."e8 ot clonic type occurred before the outcome was 
lethal. S1xty mnutes after udministntion thare va no 'igniticant elevation 
of the protect!ve ratiOS over the control leYele and the pattern ot the c0n-
vulsiOns was Id.m1la.r to the con ttool picture. At 120 Minutes there was some 
indioation of a,nergiem beween this drug and _truol bec&WJe the protective 
rattoe at the persistent convulsion level were below uni V. 
.. 
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'lb_e findings at 120 minute vaiting '!'8" in agreement with those by . 
Henze arId r:pul"lock (19Ll) who could not detect any anticonvulsive properties 
of this <.lOn1pOWld. Thu would indicate that their determinations were run only 
tif'tar a longer time period elapsed following ad:ministration or the drug. The 
present rest:lts showed a limited protective aotivity at shorter 'Waiting period!! 
with pronounced ability tornrodii'y tho eonVllleive pattem at the five minute 
interval. 'lhe significance ot the abtlity to modify eonwl.slve pattern 1s 
stressed br 'JX)man, Swinyard, and Goodman (19~6). ihey shoved that the eftica'" 
cy of t."le antiepUeptic compound !'tay b$ SOl\'.etlmes better related tc the de-
creased abili. ty of the brat.'i to support self sustaining discharges than to a 
aL."ple increase in the cbeJd.eal or electrical threshold tor in! t1ating dis-
charges.. '1he o-ast example of this phonoMnon 1& the ability of dUantin to 
a1>o11lh the t.eflic $Xten8ion ot the hind legs of rats caused by supramax1mal 
electroshock 'While on the other hand dilantin is ineffective in raising the 
conTulsive thrC'"shold or matraaol. 
'lb& following graph, where tho protective ratios of the persistent 
eonvu.lsion thrqhold are plotted against time after medication, will help to 
S'l.mt'l':'lariB9 the results obtained vi til the tested compoundB. (Figure 1, pg. 52). 
lbe question ~ ariae concerning the reliability ot the results 
obtained b7 this metraaol :S.n:f'usion technique. :!he author vas able to demon-
strate that barb! tal at doses, which did not cause any depressive aymptome. 
increased the con'VUl..81on 'f:b.Naholds to a moderate degree. 'Ibis doubt ari8_ 
becauso it is known that barb! tal, 8.11 Wi til mst CO'rmton barb! turatea, is ef-
~otu-riVt toto 
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'ille prowctive rn.U.O below 1.00 ind1..ea~ 'Um:t, thft ~md acta 
s1llof'((....st1oally v1 th _traGl. The prcteotiV6 rnt:i(\ QQ',lAl to 1.00 is the con-
trol valu.e. obtained wU;h untreated ani-mltlB. Arr:I Yt'Uu. abovfl: 1.00 1..ndtot,t.-
that compou.'ld 18 alltagonizing the llletNaol afti,ct. lho d.o,~a tt.dniniaterEtd aN 
u indicated in the graph wah tbft aCttp~on that '~-al1yl oorbi t-Al WA~ g1van 
at t. ... live n1nute period in tho dose, 5') mg/kg. 
SJ 
fectiy. as an anticonvulsant in the subcutan~s metrasol test only at d088S 
causing depressive symptOl!l8 (SVinyard, 1947). l'urthomo%'e, Orloff18, (191$9) 
results with phenobarbital using intravenous met-ruol in.t"uelon indicated that 
it is equipotent to tridione or perhaps even !1Ote effeotive because 1 t 1'JOdi-
fled the fatal tonlc convulaJions to clonic tqpe and prevented the OCeUl"Z"{:.nee 
specific LlI'1t1metruol aotd.vit.y ('r'Omarl, Goodman and f:Winyard, 1946) anci giVes, 
in the 8ubcut&"leoua metratlol &8s.,.., better values tha!) phetiobarbital (O~ 
and 'l'oman, 19h5). '.!berefore, it seems that the metruol intusion technlqutl 
of Orloff at &1., (1949) 18 likely to rive higher protective rat-loe than the 
--
older 'MOtrase1 methods for dnlge of the barbi turl'lte seri .. _ For this reason 
the comparatively good results obtained with N .. allyl phenorJ&:rbital and li-allyl 
barbital at the peak of $lotion should be accepted oautiouely insofar 88 poten-
tial. clinical application i8 concerned. Another limiting factor ill such a 
oonsideration is their ehart. duration of acu.cn. But. the agreement betweGn 
the values for trldione obtained 1>7 both metruol tests (Orloft et. 81., 1?L9) 
--
gives support to the general validity of th~ retrults obtained by the metrasol 
infusion technique. 
In conclusion ot the d:1scuadon it Clan be mentioned 'that antirnatruol 
ar.t1vit;r 18 01117 a r.onepe:eiticindex for the possible antiepileptic aotivit,. 
and does not differentiate the antigrand mal and anUpetit mal. streeti," com ... 
pounds t~ eaoh other (}~erett, 19L6). 
B. The Barb! turate ReveJ'8a1 St.udies with Succinate. 
"Dle8e exper1ment.s were designed to tumieh information whim might 
prove he1ptu1 in explaining the antagonisM betveen barbiturates and succinate 
demonstrated by some vosers (Soskin and 'fau'bel'haus" 19L3. Barrett, 191t7). 
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TUE rr1,C1S OF SUCC:mATF AND SlJCCmA 'r~MA.LONA 'IE 
Otf PEN 'IOBARB! 'D\L Am'S '1I'H~ IA 
DOse Average Aneathuta Ito. of T 
Drug Pre:}a.ratlon MrJKg. IV Duration in ~. Aninals Value 
S8,B.ne 126 16 
Succin:'1c Add 212 lOS 9 
Succinic Actd Diaod1tma 212 115 20 
SUccinic Acid ntsodium L2h 99 18 
Succtn1. c Acid DUod1Dm 81.tB MJ 20 
I Succinic Acid L1.8od111M ;;~ 7$ Malonic Acid DisodiUlft 20 
Bu cctniJl11de 212 118 10 
.,-
Suooinim1de 8ltB ell 19 
Nf,'t,f'le All an:tM1.s 'Wont anr:,thetized 'tl"i th pmtob.nrbital. ~~a 
88 m.g/kg lp. 'lbe doses of succinic acid in expert-
~ent6 .3, 11, " and 6 were b.Mi8(i on the ",~ight ot" pU.re 
aoid whioh was neutrallHd with equivalent amounts ot 
It.ftOH .. 
A.ll t valuea presented indicate a probability Of 0.0,$. 
1.7.4 
1.12 
2.71 
,.28 
5.27 
0.6) 
3.811 
The results obtained in experiMent 2, 'fallle Vnl, indicated that 
tree succinic acid bad a slight but etaUstleally insignificant antagonistic 
effect on pentobarbital anesthesia. It 'Was of 1nter!8 t to try higher doaee. 
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The free suceinie acid could not be used for this purpose because of the pos-
sible highly unphysiological changes in acid ... base balance which it might cause. 
To minimize this possibility somewhat the disodium salt of the succinic acid 
was used in experiments ), 4, " and 6 (Table VIII). 'lbe sma1.ler dose (212 
had little revC!rsing effect on the pentobarb1 tal, but the large doses tried 
(424 and 848 mg/kg) effected significant rAD'Jet:ton of the sleeping time. 1he 
relationship between succinate ion dose and sleeping time duration shCMn in 
Figure 2 indicates til.at the barbiturate sntagonitml of succinate if! somewht\t 
proportional to the Cbse of 5nceinat.e ion adm:L."1istered. 'lhe~e results are 
Qualitatively Similar to the results obtained by Soskin and 'fuubenh.au~ (19h3)" 
, 
Barrett (1947). 
~I"~~ ti,m-t 
\,r1 ..,.,,", 
))0 
'00 
90 
10 
, 
~S"o 5' 
FIGURE 2 
'TSO 
'iRE FFFJ<:C T OF SUCCn:A TE ION ON 'IHE DUR}, nON OF '!HE 
PElf'lOBARBI'OO. SLEEPING TIME 
1000 
The resalt8 of ~er11'l1ents te3tinr; the I1t. Davin,: action of tru.e ... 
e1.:nate ~.n pre-renting the death ot an:btalr. poisoned. with let.ha,l clODe of pento-
barbital in~.ieated that en..lt-Oinate had no eignU'1cant effect (Table n). 'lbeae 
resttlta are Qppozed to thOft. obtAined by Soekin and 'l'm\b8nhnn.e (19L3) in rata. 
'!HE FFFFCT 011 S1JCCmA'lE, sUCC:mn~IDE ON THE Lr'lHAt 
, POSE' r:r:! "~f '1'fJ Bft~'F '1"'7". (4 sormm 
Dose 
Pxp vli;!Kg Pon tobarhi tal Survival 
\fo. I D1"'Ug prepttra tion IV Na. Ml'jfli,p IP Rate 
~. Saline 168 1 out ot 13 
!'hlCe! uie ,Acid C :tn 
~. tom of, D1sod.1um eal t) 
,., 
848 188 2 out ot 12 
~. Saline l$O S out ot 10 
t. Succini.'Il'lide 8116 ISO 6 out ot 10 
'lb. succinate 81flergis'l'll to metrazol con:YUlaive action (Table X) 
was clearly dtmonstrated by 000 ot the intravenous _truol infuaion tecbniqu 
of Orloff at al., (19h9). '1he ;)roteetive ratiO of the persistent eonwlaion 
--
threshold was decreased twenty per cent and the convul.lf1ve picture had a 
typical metruol pattern. lllere can be some doubt as to wbether or not thi8 
phenomenon is tl"Ue synergism or whether 1 t 1s due to gerural lowering ot the 
convulsion tttreabold caused by water balance changes in the bod7. S"Irinyard, 
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'roman and G(}odman (191~6) 'USed 11>01'1\01ar glucos~ parttntol"al iI>'Joc:tJone ami the 
l.iubsequont l"6l'::1oval of & volume of peritoneal fluid or oOl'lvon;ely ord.l water 
feeclinp was utlcd to produce cell h¥dration of t.he an1l1lSl.a. Tbose h¥drated 
s:l1imals shoved both lOWG1"8d lI1(:1;tra.:.:ool and electrcohock throah.:>lds. '';'he injoc-
t.ion of hyp .. rto1l1c l;acl 8clut:.on .ul'c.o hydra::.Gu urd,.:~iln railiad thot>o two 
lowered convuls~on t.hr&sbolds to the normal laVlilla or in noI'lw aninlalu it 
increased th~s. thresholds up to twenty per cent. It seeNSt.hat the increase 
volume of the &xtracfillular tluid did not lower the convulsive t.hrE:loholds. 
1neretoN, in the experimtmta performed b:t the a.uthor, where hyportcni<: solu-
tions of succinat& wor8 UlHlad, one would not tni.Spect lowering of the convulsive 
thrashold on a basiS of e1ectrr)lyte balance cha.nges. In add! tion, it was 
ahown by Klein and Olsen (1947) that the blood-brain barrier had Ii ve17 
slight. permeab11lt7 to the suecinate ion 'Which would speak against the pos ... 
sible swelling of the brain cells. It 800ma that theru 1$ no real rauon to 
believe that the i'q'dratiOl'l or the cell ccmpartmen t could be a oaUlU'! of the 
increased sensl tiv1i1y to ntetruol. '!he work by fiOvet !!o. !t.., (1947) .. Heymans 
and Jacobs (1947) indicated that succinate htul a ci1rect action on the res-
piratory center lecated in the lIledulla obloneat& which is senal tive to the 
metrazol f,rtimilition also. On a. basis of these findings and the aut.'lor'e 
NBults one would tend to think of the occurrenoe ot summation or syne:rg1n 
phenomena between _trazo1 and succina.te ion. 
'lb. experiments usiug the combination ot the equivalent MOunts ot 
m&lonic and succinic acid Eodiu1!l salts (Table VI!!, page $lt) demonstrated that 
,'xp 
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'I1lBLE X 
THF. "~.cT OF SUCC.rNIC ACID DISODIUM SALT, SUCClNDHDE. 
suce.TIne AND ~!ALOrlIC ACro nISonIUM SAt1S 
It: Co~"ruNPD SOWTIm. ON THE 
'ruRfSHOJ..D OF ~f1'':TMZOL 
CONVULS IONS 
"' 
NO. Pers18 tent 
r Twitch of Oonwls1one 
?~g/Kg cc or Ani- CC Of' 
Pr'llg Preparation I P 'Metraaol PR* mals Metrazol PI* 
Control 
15-17 gm 0.13 1.00 2L 0.42 1.00 
control. 
18-20 gm 0.16 1.00 24 0.$2 1.00 
Suce1n1c A e1d 
D1sodium** 848 0.14 0.66 18 a.lt! 0.79 
Succin1mide 84B 0.12 0.75 18 o.IJO 0.77 
succinic Acid 
D1aodiU!l'l** 1.25 0.11 0.95 19 0.33 0.79 
tA'a!orlie Acid 
DiBodiUllt,H} 375 
no. 
or 
An1-
ul..8 
24 
22 
18 
le 
19 
*Protective Ratior Tbraehold after treatment 
~oi=ml\l flrM}iold 0' 'Si:t"l"UpondIng weight group 
s;.~} 1be dose wu based on weight of pure acid which wau neutral-
ized with NaOH before injection. 
such a combination could decrease the duration of anesthesia lIigntt1ean tly 
even more than succinate alone at equivalent dose. 'these findings W(-i!'9 Just 
the oppos1te to what one would expect according to tbe soskin and Taubenbaua 
(19L) theory 'Which stated that succinate mq be the main source of energy 
tor the barbiturate depressed brain. It seemed that the clar-sical example of 
the eompeti t1ve 1nh1bi tion ~ .... vl ..,t..,.l'O ..... were malonic acid inhibited the succinic 
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detq-drogenase in succinic acid oxidation was not operating in the experiments 
pertormed here. It this were the case one would upect. the dia.ppearance ot 
the sucCinate barbiturate antagon::tn. On a buis of th .. e elq)eriMntll the 
author is inclined to think that the metabolic action ot succinate was not 
very iJI'tPortant to 1 tfJ effect in the reversal of barbit.urate dlfPl"8881on. 'lb1a 
conclusion 18 in good agreement with Klein and Olaon (1947) who etated that 
succinate, due to ito slow diftUflion into brain~ could not be COrB idered as a 
potent1al eMrgJ' source. Iri add1.t1on, the evidence !!!. ~tro suggests that 
8\\Cc1nic acid oxidation 1e not coupled with phosphorylation (La.."'"dy et at., 
--
19Uh), or the increased ~ consUMPtion caused by succinate was not capable ot 
increu1ng the "te of the depre5seci metabollc processes (FUrcbgott and 
Shorr, 19-h8). 'Ihe presence of synergism btttveen metruol and a combination at 
succinic and malonic acids ('Table X) would indicate that succinlc acid could 
exert itl antagonistic eftect on barbiturate depression b7 ita st1mulltting 
action on ner"fOWl system, al though this 8 timula tlng power i8 tllOiweak to re-
vel'S. the etreats of lethal doe .. of pentobarbital ('l"able IX). 
'lba results w11h lueolnim1de at 'b«> dilt.roo t doe .. shwed that the 
duration ot anoeth .. ia was decreased in both case. (Ta.ble VIII). '!he effect. 
of the ~r,reater doe_ 81Jl tfJ(I/kg, I.V. va ueaker than nth sucoinate at doS8 
Sh8 mg/1cg I.V. or with combination of succinate and malonate at the given dOS€'D 
~lonethele88 this effect was atat18t:leally signiticant. 'Ibe "suite in Table X 
indicate the pl"'H(mce ot a synerg18111 between metruol and S"..lccinimide, the 
.. 
The possible _chanin tor which haa been d1sC'llS8e~ 1n preceding paragrap:It!1. 
reasons for tr:y1n~ t.h1s oompound as a barbiturate HYel'8ing agent were its 
che"'lioal structural 81m11arlty to succinate ion and beoause it could be ad-
1"\iniste:red in large doses without 81multaneoUB introduction ot buic ions 
which could themselves exert some influence on the duration ot anesthesia or 
metruol Sj'net"gism. 'the resnlte obtained indicate that succ1nWde vu simi-
lar in aetlon to succinate in respect to the shortening of sleeping time 
synergism v.i. til metruol and ineffectiveness in preventirlg death from lethal 
doses of pen tobarbltal. 
'From the results obtained the author is inclined to think that the 
role of euceinic 6.010. or its dert.fttlve8 88 .. souroe at energy is not an im-
portant aspeot of 'C'.,;! 8ucc1na te action in the barbiturate depr(?'ssed animal. 
Its role 80 a nervous 87$tem st.hl'llla.nt could. be inferred from the demonstrated 
synergi.8m with metruol md previous studies by Bovat ~ !!,., (1947). He;vmans 
and .Jacobs (191:.7). Irrespective of the true mechani81'll., the effeetlveness of 
t,1t1.a stimulat1ng power , .. Minl'"!4l because thfl author could not danonstrate any 
lj.fe-eavinr, action by .ucoinic a.cid end its derlvaUvea .. in animals poisoned 
with pentobarbital. 
c. 'lbE' Studiee of the Analeptic Properties ot "S(1,3-ril'tetbylal1yl) 
f'thyl B8l"b1 turie Aoid.· 
The pttrpOGe ot the following e:n:peri:menta wu tc detertrt1ne the ana-
leptic value ot the ',$(1.3-d:il!tethylalt),l) othyl barbituric acid. 
'Ihe injection of l~o 'Mg/lcr, intravenously caused the appearance ot uni-
form 8)'!'1lptoma :in mice. After the injaction the anllftal8 .ho ..... d a very strong 
axe! tement which ended invariably wHh convulsive death. 'lbe detailed des-
cription of the symptoms 1s as follOVll: wild running, jumptng, 1IaOUth bleeding 
due to biting of wngue, straub tail reaetion, rapid napiration, tonic clonic 
convulsiOns and Uflt'lOordinated leg move"'lfllta after animala weN exhausted and 
near doath. 'lb. deaths occurred e1. ther instantaneously after completion o~ 
injection (three eases out of ten), or after a five minute interval (Beven 
eases out of ten). 'lhe fatal convulsion picture liM very similar to that 
caused by metrazol £«bib! t.ing the tonic flexor and extensor phases with the 
head bent ventrally. 'lhoaEJ observations indicated that the drug had a very 
strong convulsive eharacter and was more potent than metraaol on a basis ot 
the le 1bal dose. 
'nle 1njecM.on of this st1mlating drug after adlWlistrat.ion of pento-
barbital did. not C3U88 any convulsive SjlmPtoMa whieh BoomB to indicate that 
the convulsive properties ot thia dJoug were completely antagonised by thiS 
lbarbiturate. Thea. tind1ng8 are in agreelftEl'lt with Taylor and Noble (19h9>., 
~o fJX8l!!ined the phamacolog1cal properties of tJ~ 8 ane drug in the dOg. 
1o:'!1m11ar resul ta were obtained w:tth other eonwls! ve barb1 tllratea by Swanson 
and Chat (1939), Knoefel (19ItS), ~foble (19b.9. On the buis ot the et1rm1l.at1ng 
IPropertl. reported in 1be literature and prelimiMr.Y tlndinga by the author 
expet".i.menta were undertaken to determine the efteet of this drug on the dura-
tion ot barbiturate anesthesia. The experimental work ot this aspect ot the 
Iletion Qf the ems of convulsive barb1turatell has not been reported in liter-
.. 
ature previously. The f'inrlings in Table XI indicate that "the S,S{l,.3-d1methyl 
allyl) ethyl ba.rbituric aCid was able to decrease .1gnificantly the dura.tion 0 
anesthesia. '1"hese findings can be indirectly Bupported by the results by 
Vellu. et al., (19S1b) who reported that the stimulating bubiturates could 
--
antagonize the respira1'l:l Z7 de;:ression caused b.Y morphine and shorten the dura-
tion of apnea after lVPerVEll tllatton in guinea pigs. 'the resulte on the re-
versal of the lethal ettecta ot pentobarbital overdosage 11x:llcated no 6ignlfl-
can t protection a1 fbough no synergism between these tt«:l drugs was observable. 
1heso findings corresponded to those of fwanaon and ~'1.en (1939), and Knoerel 
(19h6, who used sl'1Jtilar convulsive ha.:rhiturates in attempts to reverse the 
lethal efrect of barbiturate.. Tbf\ :first wrkOl"S reported a slipht synergism 
betVC;er\ depresflive and stbm.lat1 ng barbiturates. 
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'IABLE XI 
nm lCJ:+'FEC'l' OF 5,.s(J,3 ... D1V~:nfn..ALl.YL) E:'ffiYL 
:1AHBI'tnmc ACID OU THE DEPRmSIVE 
AC'rrVI'lY OF' PENWBARBITAJ .. SODIUM 
IDoee Pentobarb1 tal 
~1g/Kg !·,~a 
Drug Preparation IV '~';Kg IP Results 
>.5( 3,J-DimethYl- Average Sleep-
allyl Rt.hy'l ing T1M -
Bar{,i turie Acid 62 ~tee 
Na Salt hO 8B 
Same ae in 1. ho 188 Six died out of 
twelve animals 
Saline 88 Average sleep-
ing 'l'1me -
126 t.f1nutea 
No. ot 
Ani-
male 
13 
12 
16 
IJ~. Saline 1CE Seven died out of 
twelve animals 12 
. ?~otef t value presented ind1cates a probability of 0.05 
t 
Value 
5.62 
63 
~ 
On a basis ot tbase findings it is concluded that the $.S(1,3-01-
. 
1'!!ethyl8,lly1) ethyl barbituric acid exhibited antagoniSm to pentobarbital 
at the dose tested, as shown by the decrease of U. 818sthetlc dul-ation, but 
was W1thout erroct on the lethal effect of pentobarbi. tal in lliae. 'lhase 
"aut te should be transfe1"J"ed to other SpEI Ci.8 wry caref'ulq- because great 
tion of this class ot barb! turates (Swanson and Chen, 1939, > Richards, 19.5l). 
.. 
~tudi_ have bmm undcn-taken to evaluate the pha.nacolog.lcaJ. effects 
or N-alkyl wbsti tutions on hypnotic ba:rbi turate !'I\Oleeulee. It has been as-
oertained that !l-alkyl lJubati tut10n wl th the allyl radical on barbital pro-
duced a quantitative increase in the intensity of the ant1convuleant activity 
of the molecule as me.u.red by the intravenous metrasol intll810n test. SUch 
subst! tu ti on decreased the lata'lt penod for manifestation of the peak of 
antlconvuleant activity by barbital but also seemed to decrease the duration 
of suob acUrt ty. N-aUyl 8ubsti tution on phenobarbi tal yielded a compound 
w:tth acmevhat reduced ant1con'YUlsive potenq. In addition, this structural 
at teration of the phenobar'bi tal molecule decreased the latent penod. ot the 
peak ot action and the duration ot such activity. U-phenaC7l substitution on 
phenobarbital yielded a compound wi th reduced anticonvulsive etfect and a pos-
sible S;yt'l8rg18t1o effect with Metruol late in the course of i te action. No 
analoO' to the morphine reft'l'81ng effect of tl-allyl nomorphine (N-allyl sub-
st1 tuUon on morphine) was seen in the case ot expelimenta in which 1t-allyl 
barbiturates weN used in attempts to effect revel"8al of the snesth88ia and 
toxiei t7 erreeta ot hypnotic barbi tura tea. 'lb. oba .... ed effects were of the 
synergistio nature. At doses tried, the alkyl 8ubstl tllted compounds exh1bi ted 
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increased inttl1s11;y of anesthetic potency over that demonstrated by the parent 
col'!'JPOunds.. 'Ibis anesthesia was charactel'lsed by short duration, swift induc-
tion and fleeting post-anesthetic depression, all being properties in direct. 
contrast to thoac of the parent. molecules. 
F:Jq>.:r1menta with succinic acid, succinUdde and a combination ot suc-
cinic and malonic acids indioated that these CClMpounds and thia combin<ltion ot 
COl'l1JJOUnds decreased the duration of pentobarbital ar.esthes1a tmd showed a syn-
ergistic action with metruol in intravenous _truol infurrton t.6G te. !~ 80, 
the protection afforded b;y theee {:ompounda agatns t lethal dOf:le8 of pento-
barbi tal vaa negligible. 
Analysis ot the analeptic effects of a convuJ.sive barbiturate S,S 
(3,)-d!methylal1yl) eth1'l barbituric acid wu carried out. 1hls <.'QTIlpOund ex-
hib! ted high 6 tlmulat! "Ie potency Q..'ld caused a reduction in pen tobarbl tal 
anesthesia duration but was wi~out etfeet on the lethal dos. of pentobarbital 
. i 
I 
.. 
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